UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Form 10-K/A
Amendment
No. 1
(Mark One)
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended June 30, 2008
|
or
|
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
|
Commission file number 000-06516
Datascope Corp.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
13-2529596
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
14 Philips Parkway
|
|
07645
|
Montvale, New Jersey
|
|
(Zip Code)
|
(Address of principal executive offices)
|
|
|
(201) 391-8100
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to section 12(g) of the Act:
Title of Each Class
Common Stock, par value $0.01 per share
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act.
Yes
o
No
þ
Indicate by check mark if the registrant is not required to file reports pursuant to
Section 13 or Section 15(d) of the Act. Yes
o
No
þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes
þ
No
o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K.
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company.
See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
o
|
|
Accelerated filer
þ
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act.): Yes
o
No
þ
The aggregate market value of the common stock held by non-affiliates of the registrant as of
December 31, 2007 was approximately $472 million. As of October 21, 2008, there were 15,900,677
outstanding shares of the registrants common stock.
Explanatory Note
Datascope
Corp. (the
Company
or
Datascope
) is filing this Amendment No. 1 to our Annual Report on
Form 10-K (the
Form 10-K/A
) for the fiscal year ended June 30, 2008, as originally filed
with the Securities and Exchange Commission (the
SEC
) on September 15, 2008 (the
Original Form 10-K
), to provide the
information required in Part III of the Original Form
10-K. There are no changes to the disclosures in the Original Form 10-K, except that this Form
10-K/A amends and restates, in their entirety, Items 10 through 14 of Part III and Item 15 of Part
IV, of the Original Form 10-K. This Form 10-K/A does not reflect events occurring after the filing
of the original Annual Report on Form 10-K and, except as described above, does not modify or
update our previously reported financial results or other disclosures in the Original Form 10-K.
The information in Part III referred to above was to be incorporated into our Original Form
10-K by reference to our definitive proxy statement. Our proxy statement will not, however, be
filed with the SEC within 120 days after the end of our fiscal year, June 30, 2008, and we are
therefore filing this Form 10-K/A so that such information is incorporated within the required time
period.
We are also revising Item 15 to incorporate by reference the exhibits we filed with our
Original Form 10-K and to include Exhibits 31.1, 31.2 and 32.1, the certifications of our
principal executive officer and principal financial officer, which, as required by Rule 12b-15 of
the Securities Exchange Act of 1934, as amended, are filed as exhibits to this Form 10-K/A.
DATASCOPE CORP.
FORM 10-K/A (Amendment No. 1)
TABLE OF CONTENTS
PART III
Item 10.
Directors and Executive Officers of the Registrant
DIRECTORS OF THE COMPANY
Set forth below are the name, age and principal occupation or employment of each director of
Datascope:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Principal Occupation or Employment
|
Alan B. Abramson (1)
|
|
|
62
|
|
|
Attorney and President of Abramson Brothers, Inc.
|
David Altschiller (2)
|
|
|
67
|
|
|
Chief Executive Officer of Altschiller Assoc., LLC.
|
David R. Dantzker, M.D. (3)
|
|
|
65
|
|
|
Partner of Wheatley Partners, L.P.
|
Robert E. Klatell (4)
|
|
|
62
|
|
|
Director
|
James. J. Loughlin (5)
|
|
|
65
|
|
|
Director
|
Lawrence Saper
|
|
|
80
|
|
|
Chairman of the Board and CEO of Datascope Corp.
|
William W. Wyman (6)
|
|
|
70
|
|
|
Independent Management Consultant
|
|
|
|
(1)
|
|
Mr. Abramson has served as President of Abramson Brothers, Inc. since 1972.
|
|
(2)
|
|
Mr. Altschiller has served as a consultant to the Company since 1998. Mr. Altschiller ran
various advertising agencies as Chief Creative Officer, Chairman and CEO, including Altschiller,
Reitzfeld, Inc., Altschiller & Co, and Hill Holliday/Altschiller. Since January 2001,
Mr. Altschiller has been the Chief Executive Officer of Altschiller Assoc., LLC.
|
|
(3)
|
|
Dr. Dantzker has served as a partner at Wheatley Partners, L.P., a New York-based venture
capital firm, since January 2001. Prior to serving with Wheatley, Dr. Dantzker served as Chief
Executive Officer of Redox Pharmaceuticals Corporation from November 2000 until October 2001. Dr.
Dantzker served as President of Long Island Jewish Medical Center from July 1993 to October 1997
and President of North ShoreLIJ Health System from October 1997 until May 2000. Dr. Dantzker was
chairman of the board of directors of Versamed, Inc., a private medical supply company and is
presently chairman of Oligomerix, a private biopharmaceutical company. He is also a director of
Visionsense, Ltd., a private medical technology company, Advanced Biohealing Inc., a private
specialty biotechnology company, NoraRay Inc., a private medical technology company, Neuro-Hitech,
Inc. (NASD: NHPI), an early stage pharmaceutical company and Comprehensive Neurosciences, a
psychiatric care and drug testing company.
|
|
(4)
|
|
Mr. Klatell served as Chief Executive Officer of DICOM Group plc from December 2005 until his
retirement in December 2007. Mr. Klatell served as Executive Vice President of Arrow Electronics,
Inc. from July 1995 until December 2003 and served on the Board of Directors of Arrow Electronics,
Inc. from May 1989 to December 2003. Mr. Klatell is also Chairman of the Board of Directors and
Chairman of the Nominating and Corporate Governance Committee of TTM Technologies, Inc.
|
|
(5)
|
|
Mr. Loughlin served nearly 40 years with KPMG LLP until his retirement in 2003. From 1995 to
2003, Mr. Loughlin served as a Global Lead Partner in KPMGs Healthcare Practice. Mr. Loughlin also
served as a member of the Board of Directors of KPMG and as chairman of the Pension and Investment
Committee of the KPMG Board from 1995 to 2000. He served as a non-Board member of the Pension and
Investment Committee thereafter until 2003. Mr. Loughlin is also a member of the Board of Directors
of Celgene Corporation and Alfacell Corporation.
|
|
(6)
|
|
Mr. Wyman has served as an independent management consultant since 1995. Mr. Wyman was a
founding partner in the consulting firm, Oliver, Wyman & Company, where he served from 1984 to
1995. Previously, he served as President of the Management Consulting Group at Booz, Allen &
Hamilton in a career that began there in 1965. He has served as a director of 13 corporations, and
is currently a director of Pegasystems Inc., Allston Holding, LLC, and Dice, Inc.
|
2
EXECUTIVE OFFICERS OF THE COMPANY
The following table sets forth the names, ages and all positions and offices held by
Datascopes present executive officers. Unless otherwise indicated below, each person has held the
office indicated for more than five years:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Positions and Offices Presently Held
|
Lawrence Saper
|
|
|
80
|
|
|
Chairman of the Board of Directors and Chief
Executive Officer
|
Henry M. Scaramelli
|
|
|
55
|
|
|
Vice President, Finance and Chief Financial
Officer (1)
|
Fred Adelman
|
|
|
55
|
|
|
Vice President, Chief Accounting Officer and
Treasurer (2)
|
Nicholas E. Barker
|
|
|
50
|
|
|
Vice President, Corporate Design (3)
|
Robert O. Cathcart
|
|
|
48
|
|
|
Vice President; President, Interventional
Products Division (4)
|
Timothy J. Krauskopf
|
|
|
47
|
|
|
Vice President, Regulatory and Clinical
Affairs (5)
|
Antonino Laudani
|
|
|
49
|
|
|
Vice President and Chief Operating Officer
(6)
|
Boris Leschinsky
|
|
|
43
|
|
|
Vice President, Technology (7)
|
|
|
|
(1)
|
|
Mr. Scaramelli has been employed by Datascope as Vice President,
Finance and Chief Financial Officer since August 2007. From
September 2003 to August 2007, Mr. Scaramelli served as Vice
President, Corporate Controller and also served as Acting Chief
Financial Officer from April 2007 to August 2007. From June 2004 to
the present, Mr. Scaramelli served as Acting Vice President of Finance
for the Interventional Products Division and InterVascular, Inc. From
July 2002 to August 2003, Mr. Scaramelli served as Group Vice
President, Finance for the Cardiac Assist Division and InterVascular,
Inc. From October 1996 to June 2002, Mr. Scaramelli served as Vice
President, Finance for the Cardiac Assist Division.
|
|
(2)
|
|
Mr. Adelman has been employed by Datascope as Vice President, Chief
Accounting Officer since July 2002 and Treasurer since May 22, 2008.
From October 1999 to June 2002, he served as Corporate Controller.
From July 1983 to October 1999, Mr. Adelman was employed by Datascope
as Director of Corporate Accounting.
|
|
(3)
|
|
Mr. Barker has been employed by Datascope as Vice President, Corporate
Design since December 1997.
|
|
(4)
|
|
Mr. Cathcart has been employed by Datascope as Vice President;
President, Interventional Products Division since May 2005. Effective
November 8, 2007, Mr. Cathcart has also been serving as Vice President
Sales, Cardiac Assist Division (Acting). From November 2004 to
April 2005, he served as Vice President; President, Interventional
Products/InterVascular Group. From July 2004 to October 2004,
Mr. Cathcart served as Group Vice President of Sales for Cardiac
Assist, InterVascular and Interventional Products. From October 2001
to June 2004, Mr. Cathcart served as Vice President, Sales for the
Cardiac Assist Division.
|
|
(5)
|
|
Mr. Krauskopf has been employed by Datascope as Vice President,
Regulatory and Clinical Affairs since February 2006. Prior to joining
Datascope, he served as Senior Vice President for Regulatory and
Clinical Affairs for Cardiac Assist, Inc. from March 2002 to
December 2005.
|
|
(6)
|
|
Mr. Laudani has been employed by Datascope as Vice President and Chief Operating Officer since
October 21, 2007. He served as Vice President; President of Cardiac Assist and InterVascular from
June 2007 to October 20, 2007. From September 2006 to June 2007, he served as President of
InterVascular, Inc. and Group Vice President of Cardiac Assist, Interventional Products and Patient
Monitoring for Europe, the Middle East and Africa (
EMEA
). From July 2005 to September
2006, he served as President of InterVascular, Inc. and Group Vice President of Cardiac Assist and
Interventional Products for EMEA. From February 2005 to June 2005, Mr. Laudani served as Group Vice
President for Cardiac Assist, InterVascular and Interventional Products for EMEA. Mr. Laudani
served as Group Vice President of Sales for Cardiac Assist, InterVascular and Interventional
Products for EMEA from June 2004 to January 2005. From June 2002 to May 2004, Mr. Laudani served as
Vice President, Cardiac Assist for EMEA.
|
3
|
|
|
|
(7)
|
|
Mr. Leschinsky has been employed by Datascope as Vice President,
Technology since July 2005. From August 1990 until June 2005, he
served in various engineering positions in the Research and
Development Department of the Cardiac Assist Division.
|
THE BOARD OF DIRECTORS AND BOARD COMMITTEES
As
of the date of this Form 10-K/A, the Board of Directors of Datascope
(the
Datascope Board
) has seven directors and maintains an
audit committee, a compensation committee and a nominations and corporate governance committee.
The current membership and the function of each of these committees are described below. Other
than Messrs. Altschiller and Saper, each of our directors is independent as defined under the
National Association of Securities Dealers, Inc.s listing standards. Mr. Loughlin is the Lead
Independent Director of the Datascope Board.
During the fiscal year ended June 30, 2008 (
Fiscal 2008
), the Datascope Board held
15 meetings. Each of the directors attended 75% or more of the aggregate number of meetings of the
Datascope Board and committees on which he served. Directors are encouraged to attend the Annual
Meeting of Stockholders, and all members of the Datascope Board attended Datascopes Annual Meeting
of Stockholders in December 2007. There were also two consents executed outside of the Datascope
Board and committee meetings during Fiscal 2008.
The Datascope Board has an audit committee (the
Audit Committee
) comprised of
Messrs. Klatell, Loughlin, Wyman and Dantzker. Each of the members of the Audit Committee is
independent as defined under the National Association of Securities Dealers, Inc.s listing
standards. The primary functions of the Audit Committee are to monitor the quality and integrity
of the audits of Datascopes financial statements, to monitor the financial reporting process and
systems of internal controls regarding finance, accounting and legal and regulatory compliance, to
monitor the independence, qualification and performance of Datascopes independent registered
public accounting firm and to provide an avenue of communication between the independent registered
public accounting firm, management and the Datascope Board. The Audit Committee also receives
information generated by Datascopes anonymous system for reporting violations of its ethics and
business practice policies. The Audit Committee held nine meetings during Fiscal 2008. The
Datascope Board has determined that Mr. Loughlin is a financial expert and independent as defined
under applicable SEC rules.
The Datascope Board has a compensation committee (the
Compensation Committee
)
comprised of Messrs. Abramson, Klatell and Loughlin. Each of the members of the Compensation
Committee is independent as defined under applicable National Association of Securities Dealers,
Inc.s listing standards. The primary responsibilities of the Compensation Committee are to
discharge the Datascope Boards responsibilities relating to compensation of executive officers, to
produce an annual report on executive compensation for inclusion in Datascopes proxy statement and
to oversee, review and advise the Datascope Board on the adoption of policies that govern
Datascopes compensation, equity and employee benefit plans and programs. The Compensation
Committee held ten meetings during Fiscal 2008.
The Datascope Board has a nominations and corporate governance committee (the
Nominating
Committee
) comprised of Messrs. Abramson, Klatell and Wyman. Each of the members of the
Nominating Committee is independent as defined under applicable National Association of
Securities Dealers, Inc.s listing standards. The primary objectives of the Nominating Committee
are to develop and recommend to the Datascope Board a set of effective corporate governance
policies and procedures applicable to the Datascope Board, to identify individuals qualified to
become members of the Datascope Board and its committees and to recommend to the Datascope Board
the nominees to stand for election as directors and to review and recommend compensation of the
members of the Datascope Board and its committees. The Nominating Committee recommends candidates
based on their business experience, diversity and personal skills in technology, finance,
marketing, financial reporting and other areas that are expected to contribute to an effective
board of directors. The Nominating Committee employs several methods to identify candidates, which
include obtaining recommendations for candidates from members of the Datascope Board and
management. The Nominating Committee held three meetings during Fiscal 2008. The Nominating
Committee will consider stockholder recommendations for director sent to the Nominating Committee,
Datascope Corp., 14 Philips Parkway, Montvale, New Jersey 07645, Attention: Secretary. Any
recommendation from a stockholder should include the name, background and qualifications of such
candidate and should be accompanied by evidence of such stockholders ownership of Datascopes
common stock (the
Common Stock
).
The charters of the Audit Committee, the Compensation Committee and the Nominating Committee
are posted on Datascopes website at www.datascope.com. The Business Conduct Policy Guide of
Datascope, which covers all employees of Datascope, is also posted on Datascopes website.
4
Stockholders who wish to contact an individual director, the Datascope Board or a committee of
the Datascope Board should send their correspondence to Datascope Corp., 14 Philips Parkway,
Montvale, New Jersey 07645, Attention: Board of Directors. Each communication should specify the
applicable addressee or addressees to be contacted as well as the general topic of the
communication. Datascope will initially receive and process communications before forwarding them
to the addressee. Datascope generally will not forward to the directors a stockholder
communication that it determines to be primarily commercial in nature or relates to an improper or
irrelevant topic or that requests general information about Datascope.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires Datascopes directors and executive officers and
persons who beneficially own more than 10% of a registered class of Datascopes equity securities
(
Reporting Persons
) to file reports of ownership and changes in ownership with the
Securities and Exchange Commission on a timely basis. Reporting Persons are required to furnish
Datascope with copies of all such forms that they file. Based solely on its review of such forms,
Datascope believes that all filing requirements applicable to Reporting Persons during and with
respect to fiscal year 2008 were complied with on a timely basis other than as follows: (i) on
September 11, 2007, Antonino Laudani filed a late Form 4 reporting the grant of 30,000 restricted
stock shares on August 22, 2007; (ii) on September 11, 2007, Henry Saramelli filed a late Form 4
reporting the grant of 10,000 restricted stock shares on August 22, 2007; (iii) on January 9, 2008,
David Dantzker filed a late Form 4 reporting the receipt of 689 deferred shares that were granted
on January 3, 2008; and (iv) on September 18, 2008, Timothy Krauskopf filed a late Form 4 reporting
the issuance, on August 4, 2007, of 214 shares of Common Stock in his 401(k) plan and the
subsequent sale, on October 4, 2007, of 220 shares of Common Stock.
Item 11.
Executive Compensation
The Compensation Committee
Alan Abramson, Robert Klatell and James Loughlin are the members of the Compensation
Committee. Mr. Abramson, who has served on the Compensation Committee for eleven years, is the
chairperson of the Compensation Committee. Each member of the Compensation Committee is an
independent director as defined under applicable National Association of Securities Dealers, Inc.s
listing standards as well as the charter of the Compensation Committee. The Compensation Committee
is appointed by the Datascope Board and is governed by a written charter adopted by the Datascope
Board. A copy of the charter is available on Datascopes website at
www.datascope.com
.
The primary responsibility of the Compensation Committee is to review, approve and administer
Datascopes compensation programs and to review and approve the compensation of the executive
officers of Datascope, including base salary, annual cash bonus, long-term cash incentives,
equity-based incentive compensation, change-in-control benefits, perquisites and general benefits.
As set forth in its charter, the Compensation Committee determines which employees are
executive officers whose compensation is subject to its review and approval. The Compensation
Committee has determined that the executive officers for this purpose are the Chief Executive
Officer (the
CEO
), each of the CEOs direct reports and the head of each division. All
of the named executive officers are executive officers as determined by the Compensation
Committee. In addition, the Compensation Committee also reviewed the compensation and termination
package of Adam Saper, former Director of Business Development, Patient Monitoring Division, who is the
son of Lawrence Saper, the CEO.
Compensation Committee Interlocks and Insider Participation
No person who served as a member of the Compensation Committee during Fiscal 2008 was a
current or former officer or employee of Datascope or engaged in certain transactions with
Datascope required to be disclosed by regulations of the SEC. Additionally, there were no
Compensation Committee interlocks during Fiscal 2008, which generally means that no executive
officer of Datascope served as a director or member of the Compensation Committee of another
entity, one of whose executive officers served as a director or member of the Compensation
Committee.
The Compensation Committee Process
Datascopes compensation process for executive officers involves both the Compensation
Committee and certain members of senior management, principally the CEO, the Chief Financial
Officer, the Chief Operating Officer and the Vice President, Human Resources. These members of
management principally assist the Compensation Committee in establishing business performance
targets and objectives, evaluating the performance of employees and recommending salary levels,
cash incentive awards and equity awards for executive officers.
5
They present the Compensation Committee with historical breakdowns of the components of
compensation for each executive officer, as well as the total compensation earned, and make
recommendations for each executive officers overall compensation package for the following fiscal
year. The CEO provides an evaluation of the performance of the senior executive officers,
including the named executive officers but excluding himself. The Compensation Committee reviews
the recommendations of the CEO carefully in light of his working relationship with the other
executives and his direct knowledge of their contributions to and goals for continuing achievement
with Datascope. In evaluating the performance of the executive officers, the Compensation
Committee does not rely solely on predetermined formulas or a limited set of criteria and may
accord different weight at different times to different factors for each executive officer.
Pursuant to the charter of the Compensation Committee, the Compensation Committee has the
authority to select and retain consultants. The Compensation Committee engaged Pearl Meyer &
Partners (
PM&P
), an independent consulting firm, as its compensation consultant beginning
in 2006 to assist the Compensation Committee in considering future executive compensation. Under
the terms of its engagement, PM&P reports to, and may only
accept assignments approved by, the
Compensation Committee. The Compensation Committee has from time to time requested PM&P to
identify specific peer groups of companies, to provide research regarding compensation programs and
compensation levels among the companies in the peer groups, to perform market benchmarking
compensation studies, to assist the Compensation Committee in evaluating the design of the
compensation programs and to provide ongoing advice with respect to the compensation programs for
the executive officers and non-employee directors. In May 2007 (for Fiscal 2008), PM&P conducted a
competitive market review of the CEOs compensation. In May 2006 (for the fiscal year ended June
30, 2007 (
Fiscal 2007
)), PM&P conducted a competitive market review of the compensation
for the CEO and each of the other named executive officers based on analysis of the compensation
practices of general industry peer companies and CEO Founders Data (defined below), as well as
several broad-based general industry compensation surveys. At the direction of the Compensation
Committee, PM&P meets with management to receive and review the information received from
management.
The Compensation Committees process for determining compensation for the executive officers
generally begins with management presenting to the Compensation Committee its compensation
proposal. The Compensation Committee evaluates the proposal in light of the information provided
by PM&P and may discuss the proposal with PM&P to obtain its input. If the proposal is acceptable
to the Compensation Committee it will then approve it, with such adjustments to the terms of the
proposal to the extent the Compensation Committee deems advisable. If applicable, the Compensation
Committee will then submit the proposal, as so adjusted with any changes deemed advisable by the
Compensation Committee, to the Datascope Board and, if required or
advisable, to the stockholders of
Datascope for their approval.
The Compensation Committee meets as often as needed to perform its responsibilities. In
Fiscal 2008, Compensation Committee held ten meetings. The Compensation Committee communicates
with management to develop the meeting agenda in advance of each meeting and members of management
are often invited by the Compensation Committee to participate in meetings. The Compensation
Committee also meets with Dechert LLP, outside counsel to Datascope, and PM&P. The Compensation
Committee periodically meets in executive sessions without management.
Although many compensation decisions are made in the first quarter of the fiscal year, the
compensation planning process continues throughout the year. Business planning, evaluation of
management performance and of compensation programs, consideration of the business environment and
monitoring of compensation programs offered by comparable companies and companies in our industry
are performed throughout the fiscal year as the Compensation Committee determines is necessary.
Information Provided by Compensation Consultants
The Compensation Committee, together with PM&P, reviews from time to time benchmarking data
with regard to its executive officer positions and annually reviews such data with regard to the
compensation of its CEO. In May 2007 (for Fiscal 2008), PM&P conducted a competitive market review
of the CEOs compensation. In May 2006 (for Fiscal 2007), PM&P conducted a competitive market
review of the compensation for the CEO and each of the other named executive officers based on
analysis of the compensation practices of general industry peer companies and CEO Founders Data
(defined below), as well as several broad-based general industry compensation surveys. In
reviewing the broad-based compensation survey data, the Compensation Committee does not consider
the specific survey participants to be material to its compensation determination process.
On September 15, 2008, Datascope entered into an Agreement and Plan of Merger (the
Merger
Agreement
) with Getinge AB, a Swedish aktiebolag (
Parent
) and DaVinci Merger Sub
Inc., a Delaware corporation (
Purchaser
) and a wholly-owned, indirect subsidiary of
Parent. Pursuant to the Merger Agreement, subject to certain conditions and as more fully
described in the Merger Agreement, (1) Parent will cause Purchaser to commence a cash tender offer
(the
Offer
) for all outstanding shares of Common Stock at a price of $53.00 per share,
net to the seller in cash, without interest and less any applicable withholding taxes (or such
other amount per share as may be paid pursuant to
6
the Offer) (the
Offer Price
), and (2) Purchaser will be merged with and into
Datascope (the
Merger
). If the Offer and the Merger are completed, Datascope will become
a wholly-owned indirect subsidiary of Parent.
In light of Datascopes proposed transaction with Purchaser and Parent, salaries of executive
officers have not yet been adjusted from their salaries in Fiscal 2008, and PM&P has not been asked to conduct a
competitive market review in 2008 (for the fiscal year ended June 30, 2009 (
Fiscal
2009
)), although PM&P did provide some competitive market data in connection with the
Compensation Committees approval of Mr. Laudanis compensation package during Fiscal 2008. The
Compensation Committee considers the competitiveness of our overall compensation arrangements in
relation to a peer group of comparable medical device companies identified by PM&P. The
Compensation Committee reviews compensation levels for our named executive officers, including the
CEO, compared to executive compensation levels at the peer group companies. The Compensation
Committee, with the assistance of PM&P, regularly reviews the composition of the peer group.
During Fiscal 2008, the peer group consisted of the following companies:
|
|
|
Arrow International, Inc.
|
|
|
|
|
ArthroCare Corporation
|
|
|
|
|
Biomet, Inc.
|
|
|
|
|
Biosite Incorporated (this company has since been acquired)
|
|
|
|
|
C.R. Bard, Inc.
|
|
|
|
|
CONMED Corporation
|
|
|
|
|
Haemonetics Corporation
|
|
|
|
|
Integra LifeSciences Holdings
|
|
|
|
|
Mentor Corporation
|
|
|
|
|
Thoratec Corporation
|
|
|
|
|
Viasys Healthcare Inc.
|
|
|
|
|
Wright Medical Group, Inc.
|
These peer companies have been selected to represent Datascopes competitive market based on
their industry focus, business mix, sales size and number of employees. Although some larger direct
competitors have been included, Datascope is comparable in sales size with the peer group median.
For Fiscal 2007, PM&P has also provided the Compensation Committee with reports regarding two
supplemental reference groups that were similar to Datascope in terms of sales and market
capitalization: (1) a comparator group of general industry companies; and (2) a group of
companies in which the founding CEO held at least 5% beneficial ownership of each companys equity
(
CEO Founders Data
).
Although the Compensation Committee reviews data pertaining to the above-described peer group,
the Compensation Committee recognizes the difficulty in choosing a group of publicly-traded
companies that has market capitalization, size and business mix that all closely match that of
Datascope. Therefore, although the Compensation Committee reviews data pertaining to our
identified peer group, the Compensation Committee does not believe that it is appropriate to
establish compensation levels primarily based on benchmarking. Furthermore, the Compensation
Committee does not target a certain percentile or the median for each compensation element shown in
our peer group, but rather considers the total compensation of our executive officers.
Nonetheless, the Compensation Committee recognizes that Datascopes compensation practices must be
competitive in the marketplace to attract and retain highly qualified key executive officers.
Therefore, this marketplace information is one of the many factors that the Compensation Committee
considers in assessing the reasonableness of compensation. In addition to compensation data for
its peer group, the Compensation Committee also considers information from other sources, such as
compensation survey data, individual performance, CEO Founders Data (especially with respect to
long-term compensation), data from the comparator group, compensation data for executives at larger
competitors in the medical devices industry, year-to-year financial and stock performance, progress
towards strategic objectives of Datascope and the individuals compensation
7
levels relative to that of other executives of Datascope. With regard to the compensation
level of our CEO, the Compensation Committee also considers the unique contributions of a founding
CEO, his status as a founder and his holdings of Common Stock.
Compensation Discussion and Analysis
Compensation Objectives
The objective of the Compensation Committee in setting Datascopes compensation policy is to
provide compensation packages that will allow Datascope to:
|
|
|
attract, motivate and retain highly qualified executive officers;
|
|
|
|
|
align the financial interests of each executive officer with the interests of the
stockholders by focusing on annual and long-term performance factors that drive
stockholder value;
|
|
|
|
|
reward executive officers for attaining desired levels of profit and stockholder value; and
|
|
|
|
|
reinforce each executive officers stake in Datascopes long-term performance and success.
|
What Our Compensation Program is Designed to Reward
Overall, the compensation program is designed to reward individual, divisional and company
short-term and long-term performance. A portion of the compensation opportunity for the executive
officers is comprised of a combination of annual cash bonuses, which reward annual executive,
divisional and company performance, and long-term cash incentives and, in certain cases, restricted
stock awards, which reward long-term growth in company net earnings performance. The Compensation
Committee believes that by weighting total compensation in favor of the performance-based
components of the total compensation program, the Compensation Committee appropriately rewards
individual achievement while at the same time providing incentives to promote company performance
(see Compensation of the CEO below for a discussion of the weighting of CEO compensation).
Because the Committee has established aggressive targets for its bonus program, bonuses have been
small in recent years and a significant portion of compensation has been in the form of salary.
The Compensation Committee does not use fixed percentages to determine the mix of base salary,
bonus and long-term incentive components. Instead, it sets cash compensation, including base
salaries at levels that are competitive with peer group companies and with the medical device
industry. The Compensation Committee then offers annual bonus and long-term incentive
opportunities based on factors such as the individuals position and responsibilities, specific
divisional and performance goals tied to the individuals position and the historic compensation of
executive officers of Datascope.
In recent years, the Compensation Committee has made two significant changes to its
compensation philosophy. First, the Compensation Committee, after consultation with senior
management, determined that those members of management who have the ability to have the most
meaningful impact on Datascopes operations and growth should participate in incentive programs.
This change was effected in order to provide meaningful potential incentives while assuring that
the appropriate portion of earnings is retained for the benefit of
Datascope and its stockholders. To
this end, the breadth of employee participation in Datascopes incentive programs was reduced
(though the participation of the executive officers in these programs was not significantly
affected). Second, the Compensation Committee has reduced the number and size of stock option
awards in favor of cash bonuses, restricted stock grants and performance-based cash long term
incentive plans. For many years, stock options were the principal form of long-term incentives
awarded to employees. The Compensation Committee has concluded that stock options are not
currently an effective method of promoting long-term equity ownership in Datascope because option
holders have tended to sell the shares underlying the options immediately upon exercise. Recent
accounting changes also require the cost of stock options to be expensed, decreasing the relative
accounting benefits of stock options as compared to restricted stock awards. In addition,
Datascope believes that it can achieve the same benefits by granting fewer restricted shares than
options, as well as by using performance-based cash long-term incentive plans, thereby reducing the
dilution to stockholders and strengthening the link between pay and long-term performance.
Proposed Merger with Getinge AB
Pursuant to the Merger Agreement, Datascope agreed to certain restrictive covenants as to the
activities of Datascope and its subsidiaries during the period from the date of the Merger
Agreement to the earlier of (1) Purchasers acceptance for payment and payment for any shares of
Common Stock tendered and not withdrawn pursuant to the Offer and (2) the termination of the Merger
Agreement. These covenants provide that, subject to certain exceptions, Datascope will not take
certain actions without the prior written consent of Parent, including, among other things: (1)
issuing, granting or awarding any right to acquire shares of Common Stock, or any options,
warrants,
8
convertible securities or any other rights to acquire or receive any shares of its Common Stock;
(2) issuing any additional shares of Common Stock except pursuant to the exercise of stock options
or other awards outstanding on the date of the Merger Agreement under Datascopes plans; (3)
increasing the compensation (including increasing any bonus opportunities) or benefits of any of
Datascopes director and officers; (4) paying or granting any pension, severance, termination or
retirement benefits not required by any existing plan or agreement, except with respect to such
benefits provided to new hires of Datascope in the ordinary course of business; and (5)
establishing, amending in any material respect, entering into or terminating any material plan
except as reasonably determined by Datascope to be appropriate to comply with applicable laws or as
may be provided to new hires consistent with past practice. In light of Datascopes proposed
transaction with Purchaser and Parent, the Compensation Committee has deferred certain decisions
with respect to determining compensation for executive officers for Fiscal 2009 until further
clarity on the timing for the consummation of the transaction is known. It is anticipated that any
compensation decisions, once made, will be made in accordance with the provisions of the Merger
Agreement.
Elements of Executive Compensation
The compensation program for executive officers consists of the following elements of
compensation, each described in greater depth below:
|
|
|
base salaries;
|
|
|
|
|
annual cash bonuses;
|
|
|
|
|
long-term cash incentives;
|
|
|
|
|
equity-based incentive compensation;
|
|
|
|
|
change-in-control benefits;
|
|
|
|
|
perquisites; and
|
|
|
|
|
general benefits.
|
As noted above, a significant portion of executive compensation is determined based on the
Compensation Committees evaluation of Datascopes and each executive officers annual and
long-term performance. Datascope provides few personal benefits to executive officers, such as a
monthly allowance for automobile expenses or a company-leased automobile. Datascope also provides
change-in-control benefits as a recruitment and retention mechanism. Finally, other than an
executive medical plan available to executive officers, executive officers participate in Datascope
benefit plans that are offered to all employees, including
Datascopes 401(k) savings plan and health
and benefit plans, and are entitled to vacation and paid time off based on Datascopes general
vacation policies.
Base Salary
Base salaries are a critical element of executive compensation because they are essential to
recruiting and retaining qualified employees and provide executive officers with a base level of
monthly income. Base salaries are initially set by the Compensation Committee with managements
input. In determining base salary levels, the Compensation Committee considers the executive
officers position with Datascope, his or her qualifications and experience, past performance,
scope of responsibilities, goals and objectives set for the executive officer and whether or not
the base salary would be tax deductible. The Compensation Committee also considers salary levels
for similar positions at comparable companies. With regard to hiring executive officers, Datascope
competes with many companies that are significantly larger in size
and which have greater resources, and,
therefore, the Compensation Committee seeks to offer competitive base salaries to attract and hire
highly qualified executive officers.
Thereafter, the Compensation Committee reviews salary levels in the first quarter of each
fiscal year and considers potential increases in base salary each year based on its subjective
assessment of Datascopes overall performance over the preceding year, as well as executive officer
performance and experience, length of service and changes in responsibilities. As part of its
review, the Compensation Committee receives reports from the CEO regarding recommendations in
salary adjustments for executive officers. When conducting its review, the Compensation Committee
obtains market information from PM&P about compensation levels for executives. In light of
Datascopes proposed transaction with Purchaser and Parent, salaries for executive officers have
not been adjusted from their salaries in Fiscal 2008, other than upon Mr. Laudanis promotion, and
PM&P has not been asked to obtain market information for positions other than the CEO and positions
similar to Mr. Laudanis. Also included in the subjective determination is the Compensation
Committees evaluation of the development and execution of strategic plans, the exercise of
leadership and involvement in industry groups. For example, Mr. Laudani
9
represents Datascope in the European Association of Medical Devices Manufacturers, Mr. Barker
is a member of the Industrial Design Association of America and Mr. Leschinsky is a member of the
American Society for Artificial Internal Organs. The weight given such factors by the Compensation
Committee may vary from one executive officer to another.
See Compensation of the CEO below for a discussion of the base salary of the CEO.
Salary increases for the executive officers are typically determined in August of each fiscal
year and become effective in October for such fiscal year. The Compensation Committee reviews the
base salaries of executive officers holding positions of similar levels within the peer group
selected by PM&P, as well as the performance of their respective divisions. In light of
Datascopes proposed transaction with Purchaser and Parent, the salaries of the named executive
officers have not yet been adjusted from their salaries in Fiscal 2008, although such an increase
may occur based on the Committees consideration of the performance of the respective divisions
that these officers lead. Additionally, PM&P has not been asked to review peer group compensation
data (other than for Mr. Laudani) in Fiscal 2008 (for Fiscal 2009).
2004 Management Incentive Plan
To support Datascopes goals of rewarding the performance of executive officers and aligning
the interest of executive officers with those of Datascopes stockholders, the Compensation
Committee awards cash bonuses to named executive officers under the Datascope Corp. 2004 Management
Incentive Plan, which was approved by stockholders in December 2003 (the
Incentive Plan
).
Awards are based on the attainment of overall corporate and division financial thresholds and
targets and certain subjective individual criteria. In the case of Mr. Saper, the threshold and
targets are limited to objective financial criteria, historically earnings per share of Datascope.
The Compensation Committee has determined that operating results, such as earnings per share, are
the best measures of executive performance, because these types of metrics motivate the executive
officers to focus their efforts on improving Datascopes overall performance. To ensure that the
objectives of the CEO and senior management are aligned, the corporate financial thresholds and
targets use earnings per share as the performance metric and the thresholds and targets are the
same for both the CEO and senior management.
The thresholds and targets are generally established within the first 25% of the measurement
period by the Compensation Committee. The thresholds, targets and formulas for calculation of
whether the thresholds and targets are achieved are submitted by management, which the Compensation
Committee considers, adjusts in its discretion and subsequently approves, subject to any
adjustments deemed advisable by the Compensation Committee. Bonuses are granted to participants if
the thresholds are achieved, and the size of the executive officers bonus increases with the level
of achievement up to a certain maximum level of bonus. However, the Compensation Committee has the
discretion to (i) decrease or eliminate the award payable to any executive (such as Mr. Saper) who
is covered by Section 162(m) of the Internal Revenue Code (the
Code
), or (ii) increase,
decrease or eliminate the award payable to any executive officer to reflect the individual
performance and contribution of, and other factors relating to, such executive officer. At the end
of the fiscal year, the Compensation Committee reviews Datascopes performance to determine whether
the thresholds and targets have been met and ensures that the Incentive Plan is appropriately
administered. The Compensation Committee determines in its discretion whether and how much cash
bonus to pay each executive officer based on its review of company and individual performance. As
a result of the pending acquisition of Datascope, the Compensation Committee has not yet determined
thresholds, targets and formulas for Fiscal 2009.
If the overall performance targets are not met in any given measurement period, the
Compensation Committee, in consultation with the CEO, has the discretionary authority to approve
bonus awards outside of the 2004 Management Incentive Plan for executive officers who have made
substantial contributions during such period. The aggregate amounts of these discretionary bonus
awards are typically lower than the amounts that would have been granted to officers if Datascope
had met its performance targets. Depending on the Compensation Committees assessment, bonuses may
be equal to, more or less than the previously established target amounts.
Performance targets are based on the operating results of Datascopes core business and
generally exclude special items of income and expense that, in the judgment of the Compensation
Committee, are less relevant to the creation of long-term value for Datascopes stockholders. The
Compensation Committee establishes targets at levels that it believes would require superior
performance from each executive officer.
In Fiscal 2008, Datascope met its performance targets and bonuses were awarded pursuant to the
Incentive Plan. In Fiscal 2008, Datascope recognized gains in connection with the sale of the
Patient Monitoring business that would have resulted in maximum bonuses being paid. The
Compensation Committee adjusted the targets for Fiscal 2008 to eliminate these gains and to reflect
the changes in Datascopes operations resulting from the sale of the Patient Monitoring business
during Fiscal 2008. Based on Fiscal 2008 performance, the following named executive officers were
granted bonuses: Lawrence Saper $496,495, Antonino Laudani $250,000, Henry A. Scaramelli $85,000,
and Boris Leschinsky $65,000. These bonuses were awarded based on the superior performance of the
respective divisions as well as the overall performance of Datascope. Mr. Laudanis bonus was
awarded based on his compensation plan when he assumed the position of
10
Chief Operating Officer in October 2007. All awards for executive officers are recommended by
management and individually reviewed and approved by the Compensation Committee.
Based on its evaluation of individual performance, the Compensation Committee also reviewed
and approved certain bonuses in addition to those awarded under the Incentive Plan for two named
executive officers. Mr. Laudani also received a bonus of $189,240 related to the sale of the
Patient Monitoring business and a bonus of $52,608 paid in Fiscal 2008 based on commercial results
of Datascopes Europe, Middle East and Africa business. Mr. Scaramelli also received a
discretionary bonus of $91,000 in recognition of the additional work required during the sale of
the Patient Monitoring business.
Long-Term Incentive Plan
The Long-Term Incentive Plan, approved by the Datascope Board on September 12, 2006 (the
Long-Term Incentive Plan
), allows for cash awards to designated executives and senior
managers whose positions enable them to manage, invest, develop or negotiate opportunities that
contribute directly to the growth of Datascopes earnings. Datascope and the Compensation Committee
believe that this plan appropriately rewards executive officers who contribute to the strategic
growth, financial strength and long-term success of Datascope. The initial implementation of the
plan measures results from Datascopes fiscal years 2007 through 2009. An additional three-year
award measures results from Datascopes fiscal years 2008 through 2010. Although a new three-year
measurement period will generally commence in each subsequent year thereafter, in light of
Datascopes proposed transaction with Purchaser and Parent, the Datascope Board has not yet
approved a Long-Term Incentive Plan for fiscal years 2009 through 2011. Datascopes performance
objectives under the Long-Term Incentive Plan for the three-year period ending June 30, 2009 and
the three-year period ending June 30, 2010 are specified levels for the compound annual growth rate
(
CAGR
) of consolidated net earnings, excluding special items. The Long-Term Incentive
Plan specifies threshold, target and maximum levels of CAGR that will determine the cash amount
payable under the plan. The Compensation Committee assigned participants a target amount, a
percentage of base pay used to calculate benefits under the plan, which ranged from 30% to 40% of
base pay. Under the Long-Term Incentive Plan, a participant can receive from 0% to 200% of the
applicable target amount, depending on Datascopes actual CAGR of consolidated net earnings,
excluding special items. To date, the CEO has not participated in the Long-Term Incentive Plan.
Each of the other named executive officers participates in the Long-Term Incentive Plan for the
three-year period ending June 30, 2009 and the three-year period ending June 30, 2010.
Equity Compensation
The Compensation Committee believes that, in addition to compensating executive officers for
the long-term performance of Datascope, the periodic grant of equity-based compensation helps align
the interest of the executive officers with those of Datascopes stockholders, thereby ensuring
that such officers have a continuing stake in our long-term success.
The Datascope Corp. 2005 Equity Incentive Plan (the
2005 Equity Incentive Plan
)
allows for awards to executives, certain types of which are based on the attainment of performance
objectives specified in the grant. The performance objectives may be based on company-wide
objectives or objectives that are related to the performance of the executive or the department or
function within Datascope in which the executive is employed. These objectives may be measured on
an absolute basis or a relative basis, which is measured in relation to a group of peer companies
or a financial market index. These grants may specify a minimum level below which no payment will
be made and may set forth a formula for determining the amount of any payment to be made if
performance is above the minimum acceptable level. The Compensation Committee may also grant stock
appreciation rights, restricted shares, deferred shares and stock options under the 2005 Equity
Incentive Plan. In light of Datascopes proposed transaction with Purchaser and Parent and
pursuant to the terms of the Merger Agreement, Datascope has agreed not to make new equity awards
pending the consummation of the Merger.
Datascope has recently used restricted stock rather than stock options as an equity incentive.
When restricted stock or stock options are granted, they are generally granted at regularly
scheduled meetings of the Compensation Committee. A grant of 30,000 shares of restricted stock was
made to Mr. Laudani in August 2007 in recognition of his performance as Vice President and Group
President, Cardiac Assist and InterVascular, which position he had assumed in June 2007. A grant
of 10,000 shares of restricted stock was made to Mr. Scaramelli in August 2007 in recognition of
his promotion to Vice President, Finance and Chief Financial Officer in August 2007. Datascope
does not have a program, plan or practice to time option grants in coordination with the release of
material, non-public information, nor does Datascope plan to time, nor has it timed, its release of
material, non-public information for the purpose of affecting the value of executive compensation.
Change-in-Control Benefits
When a change-in-control is contemplated, named executive officers may face an uncertain
future with Datascope after a change-in-control of Datascope. Datascope has entered into certain
change-in-control agreements in order to diminish the extent to which the possibility
11
of a change-in-control would otherwise distract these employees and allow the executive
officers to provide effective management and continuity during a period in which a
change-in-control is contemplated. The material terms of Datascopes change-in-control benefits are
described in the narrative section under the caption Potential Payments Upon Termination or
Change-in-Control.
Perquisites
In 2008, Datascope provided executive officers with perquisites and other personal benefits
that the Compensation Committee believed to be reasonable and consistent with the objective of
allowing Datascope to attract and retain highly qualified officers. The cost to Datascope of the
perquisites received by our named executive officers in Fiscal 2008 is included in the Summary
Compensation Table below and described in the respective footnotes.
Named executive officers have the option of receiving a monthly allowance for expenses related
to their automobiles or receiving a company-leased automobile. The value of this perquisite is
included in the Summary Compensation Table below. We believe that this type of perquisite is
important as part of a total compensation package when recruiting executive officers.
Datascope reimburses Mr. Saper for the cost of annual country club membership dues. Datascope
provides an automobile and a driver for use by Mr. Saper for business purposes. Datascope paid for
the costs of tax and estate planning advice received by
Mr. Saper in Fiscal 2007 and the Compensation Committee
discontinued this perquisite for Fiscal 2008.
Compensation of the CEO
The compensation arrangement with Mr. Saper reflects what the Compensation Committee believes
to be his unique history with, role in, and contribution to, Datascope. Mr. Saper founded
Datascope and continues to be its largest stockholder. He is responsible for, or has contributed
to the development of, most of Datascopes principal products, for which Mr. Saper neither receives
royalties nor special compensation. As is discussed in greater detail below, because of his age
and length of service with Datascope, if Mr. Saper elected to retire, his fully vested retirement
benefits would substantially exceed his compensation. Datascope has entered into an employment
agreement with Mr. Saper, dated as of July 1, 1996 (as amended, the
Saper Employment
Agreement
). The Saper Employment Agreement is for a term of five years and automatically
renews unless either party gives notice of intent not to continue to extend the term. The Saper
Employment Agreement provides for an annual base salary and increases to the base salary as
determined by the Datascope Board or the Compensation Committee. On September 22, 1999, the
Compensation Committee determined to set Mr. Sapers annual base salary at $1,000,000, and the
Compensation Committee has maintained Mr. Sapers annual base salary at this level. In
consultation with PM&P, the Compensation Committee determined that the total compensation package
provided an appropriate value for Mr. Sapers contribution to, and role in, Datascope. Mr. Sapers
total compensation is heavily weighted toward salary and annual bonuses when, and if, earned under
the Incentive Plan because the Compensation Committee determined that Mr. Sapers significant stock
ownership in Datascope creates compelling long-term incentives, rendering other long-term
incentives unnecessary. Mr. Saper was not granted a bonus in connection with the sale of the
Patient Monitoring business and is not expected to be granted a bonus in connection with the
Merger.
Mr. Sapers compensation for Fiscal 2008 was determined pursuant to the Saper Employment
Agreement. Also under the Saper Employment Agreement, Mr. Saper will be required to pay Datascope
$260,000, which represents the amount that Datascope advanced to Mr. Saper in March 2002 for
payment of a membership deposit to a country club, upon the termination of Mr. Sapers membership
in the country club or, if earlier, upon the termination of Mr. Sapers employment with Datascope;
this amount may be offset against amounts that Datascope owes to Mr. Saper and any imputed interest
on such advance is treated as compensation. Mr. Saper may terminate the Saper Employment Agreement
for good reason, including a significant breach by the Company of its obligations thereunder or
certain changes in control of the Company.
The overall compensation included in the employment agreement paid to Mr. Saper was determined
in a manner the Compensation Committee believes is reflective of Datascopes operating results, the
growth in Datascopes business and the value of Datascopes equity, and recognizes the key role in,
and contributions of Mr. Saper to, the success of Datascope and its performance.
Mr. Saper is also entitled to certain retirement benefits. See Potential Payments upon
Termination or Change-in-Control. Since Mr. Saper has not historically received long-term
incentive compensation, the Compensation Committee believes that it is appropriate for Mr. Saper to
receive retirement benefits, which it considers another form of compensation, in light of his role
and contributions to Datascope. Mr. Sapers retirement benefits were established by the
Compensation Committee on May 20, 1997 and the Compensation Committee has not made any increases to
the retirement benefits since that time.
12
Financial Restatement
It is the Datascope Boards policy that the Compensation Committee will, to the extent
permitted by applicable law, have the sole and absolute authority to make retroactive adjustments
to any cash or equity-based incentive compensation paid to executive officers and certain other
officers where the payment was predicated upon the achievement of certain financial results that
were subsequently the subject of a restatement. Where applicable, Datascope will seek to recover
any amount determined to have been inappropriately received by the individual executive officer.
Tax and Accounting Considerations
Datascope generally seeks to maximize the deductibility for tax purposes of all elements of
compensation. Section 162(m) of the Code generally disallows a tax deduction for compensation over
$1,000,000 paid to Datascopes CEO and certain other highly compensated executive officers.
Qualifying performance-based compensation will not be subject to the deduction limit if certain
requirements are met. The Incentive Plan was approved by stockholders and contains the provisions
necessary so that amounts payable to Mr. Saper and the named executive officers under the Incentive
Plan will not be subject to the deduction limitations of Section 162(m) of the Code. The
Compensation Committee reviews compensation plans in light of applicable tax provisions and may
recommend amendments to compensation plans to maximize tax deductibility. However, the Compensation
Committee may approve compensation that does not qualify for deductibility when the Compensation
Committee deems it to be in the best interests of Datascope and its stockholders.
The Compensation Committee also considers the effect of certain accounting rules on the
various compensation programs that it offers to executive officers. The Committee balances
potential accounting effects with the flexibility it needs to retain in order to take any
compensation actions that it determines are in the best interests of Datascope and its
stockholders.
Compensation Committee Report
The Compensation Committee has reviewed and discussed the foregoing Compensation Discussion
and Analysis required by Item 402(b) of Regulation S-K with management. Based on its review and
discussion with management, the Compensation Committee has recommended to the Datascope Board that
the Compensation Discussion and Analysis be included in this Form 10-K/A.
Compensation Committee
:
Alan Abramson, Chairperson
Robert E. Klatell
James J. Loughlin
13
SUMMARY COMPENSATION TABLE
The following table sets forth for Fiscal 2007 and Fiscal 2008, the compensation paid to or
earned by (i) our principal executive officer, (ii) our principal financial officer, (iii) the
other three most highly compensated executive officers of Datascope who were serving as executive
officers as of June 30, 2008 and (iv) an executive officer who left Datascope during Fiscal 2008
who was among the most highly compensated executive employees in Fiscal 2008 (collectively, the
Named Executive Officers
):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
Incentive Plan
|
|
Compensation
|
|
All Other
|
|
|
Name and Principal
|
|
|
|
|
|
Salary
|
|
|
|
|
|
Stock
|
|
Awards
|
|
Compensation
|
|
Earnings
|
|
Compensation
|
|
Total
|
Position
|
|
Year
|
|
($)
|
|
Bonus ($)
|
|
Awards ($)
|
|
($)
|
|
($)
|
|
($)
|
|
($) (1)
|
|
($)
|
Lawrence Saper
|
|
|
2008
|
|
|
|
1,000,000
|
|
|
|
496,495
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
189,320
|
(2)
|
|
|
514,505
|
|
|
|
2,200,320
|
|
Chairman of
the
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of
Directors
|
|
|
2007
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,067,621
|
(2)
|
|
|
503,154
|
|
|
|
2,570,775
|
|
and
Chief
Executive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani (3)
|
|
|
2008
|
|
|
|
530,630
|
|
|
|
491,848
|
(4)
|
|
|
171,261
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111,101
|
|
|
|
1,304,840
|
|
VP and Chief
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Officer
|
|
|
2007
|
|
|
|
371,596
|
|
|
|
183,165
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,957
|
|
|
|
615,718
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
2008
|
|
|
|
257,500
|
|
|
|
176,000
|
(6)
|
|
|
57,087
|
|
|
|
|
|
|
|
|
|
|
|
10,800
|
|
|
|
22,930
|
|
|
|
524,317
|
|
VP; Finance
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chief
Financial
|
|
|
2007
|
|
|
|
230,000
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,254
|
|
|
|
17,016
|
|
|
|
342,270
|
|
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
2008
|
|
|
|
259,250
|
|
|
|
62,000
|
|
|
|
|
|
|
|
42,900
|
|
|
|
|
|
|
|
19,706
|
|
|
|
48,844
|
|
|
|
432,700
|
|
VP; Regulatory and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical Affairs
|
|
|
2007
|
|
|
|
217,500
|
|
|
|
45,000
|
(7)
|
|
|
|
|
|
|
44,500
|
|
|
|
|
|
|
|
|
|
|
|
85,450
|
|
|
|
392,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
VP,
|
|
|
2008
|
|
|
|
226,250
|
|
|
|
65,000
|
|
|
|
|
|
|
|
43,100
|
|
|
|
|
|
|
|
443
|
|
|
|
81,533
|
|
|
|
416,326
|
|
Technology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
|
211,250
|
|
|
|
25,000
|
|
|
|
|
|
|
|
43,158
|
|
|
|
|
|
|
|
17,097
|
|
|
|
85,469
|
|
|
|
381,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
2008
|
|
|
|
257,500
|
|
|
|
90,000
|
(9)
|
|
|
|
|
|
|
199,798
|
|
|
|
|
|
|
|
822
|
|
|
|
83,950
|
|
|
|
632,070
|
|
VP;
President,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient
|
|
|
2007
|
|
|
|
260,000
|
|
|
|
20,000
|
|
|
|
66,508
|
|
|
|
|
|
|
|
|
|
|
|
6,843
|
|
|
|
84,102
|
|
|
|
437,453
|
|
Monitoring
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology
Services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Division
(former) (8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Amounts shown in All Other Compensation include the following:
|
|
|
|
Mr. Saper: auto allowance, $54,877 in 2008, $53,539 in 2007; auto maintenance,
$18,294 in 2008, $18,414 in 2007; personal commuting expenses, $10,000 in 2008,
$10,000 in 2007; payment of personal tax and estate planning services, $0 in
2008, $36,970 in 2007; annual club dues and imputed interest on loan for club
membership, $21,262 in 2008, $21,262 in 2007; reimbursement for executive portion
of split-dollar life insurance, $164,820 in 2008, $135,000 in 2007; tax
gross-ups, $189,894 in 2008, $180,563 in 2007; 401(k) Plan matching contribution,
$6,900 in 2008, $7,584 in 2007; company paid premiums for term-life insurance and
long-term disability insurance, $877 in 2008, $877 in 2007; and executive medical
plan reimbursements, $47,581 in 2008, $38,945 in 2007.
|
|
|
|
|
Mr. Laudani: payments for auto, $74,800 in 2008, $58,513 in 2007; premium for
executive medical plan $2,295 in 2008, $2,444 in 2007, payments for rent and
utilities for an apartment used by Mr. Laudani while he is in the United States
of $33,340 in 2008. All other benefits for Mr. Laudani are covered under the
Italian governments statutory benefit plans.
|
|
|
|
|
Mr. Scaramelli: personal auto, $6,065 in 2008, $4,660 in 2007; tax gross-up,
$3,998 in 2008, $3,072 in 2007; 401(k) Plan matching contribution, $10,625 in
2008, $6,600 in 2007; company paid premiums for term-life insurance and long-term
disability insurance, $1,016 in 2008, $1,016 in 2007; and executive medical plan
reimbursements, $1,226 in 2008, $1,668 in 2007.
|
14
|
|
|
Mr. Krauskopf: personal auto, $4,999 in 2008, $4,048 in 2007; tax gross-up,
$13,182 in 2008, $28,087 in 2007; 401(k) Plan matching contribution, $9,208 in
2008, $2,750 in 2007; company paid premiums for term-life insurance and long-term
disability insurance, $1,016 in 2008, $1,016 in 2007; executive medical plan
reimbursements, $4,848 in 2008, $9,464 in 2007 and personal living and relocation
expenses, $15,591 in 2008, $40,085 in 2007.
|
|
|
|
|
Mr. Leschinsky: personal auto, $10,586 in 2008, $10,580 in 2007; tax gross-up,
$23,718 in 2008, $24,733 in 2007; 401(k) Plan matching contribution, $8,163 in
2008, $6,825 in 2007; company paid premiums for term-life insurance and long-term
disability insurance, $1,016 in 2008, $1,016 in 2007; relocation loan and
interest forgiveness $26,400 in 2008, $28,000 in 2007; and executive medical plan
reimbursements, $11,650 in 2008, $14,309 in 2007.
|
|
|
|
|
Mr. Gibson: personal auto, $456 in 2008, $4,500 in 2007; tax gross-up, $24,772 in
2008, $26,404 in 2007; 401(k) Plan matching contribution, $9,176 in 2008, $6,600
in 2007; company paid premiums for term-life insurance and long-term disability
insurance, $883 in 2008, $1,016 in 2007; executive medical plan reimbursements,
$10,072 in 2008, $8,621 in 2007; and reimbursement of personal living and
relocation expenses, $38,591 in 2008, $36,961 in 2007.
|
|
|
|
(2)
|
|
The net change in post-employment benefit values
in Fiscal 2008 and Fiscal 2007, respectively, for
Mr. Saper is comprised of the following:
|
|
|
|
Datascope Corp. Pension Plan $130,134 and $18,549
|
|
|
SERP $340,779 and $1,058,476
|
|
|
Post-Retirement Medical Plan $21,325 and $27,694
|
|
(3)
|
|
Mr. Laudani is an Italian citizen and his
compensation is paid in Euros. Dollar amounts in
this Form 10-K/A with respect to Mr. Laudani have
been calculated using an average exchange rate of
1 Euro to 1.461320 and 1.308311 U.S. dollars in
Fiscal 2008 and Fiscal 2007, respectively.
|
|
(4)
|
|
Includes discretionary bonus of $189,240 paid in
Fiscal 2008 related to the sale of the Patient
Monitoring business, $52,608 bonus paid in Fiscal
2008 pursuant to the Fiscal 2007 bonus plan for
EMEA and $250,000 earned in Fiscal 2008 under the
Executive Bonus Plan.
|
|
(5)
|
|
Includes discretionary bonus of $104,665 earned in Fiscal 2007 under the Executive Bonus Plan and $78,500 bonus earned pursuant to the Fiscal 2007 bonus plan for EMEA.
|
|
(6)
|
|
Includes discretionary bonus of $91,000 paid in Fiscal 2008 related to the sale of the Patient Monitoring business and $85,000 earned in Fiscal 2008 under the Executive Bonus
Plan.
|
|
(7)
|
|
Includes a sign-on bonus of $25,000 paid in Fiscal
2007. Mr. Krauskopf began his employment with
Datascope in February 2006.
|
|
(8)
|
|
Mr. Gibsons employment with Datascope terminated on May 1, 2008, the effective date of the sale of the Patient Monitoring business.
|
|
(9)
|
|
Consists of discretionary closing bonus paid in Fiscal 2008 related to the sale of the Patient Monitoring business.
|
15
GRANTS OF PLAN-BASED AWARDS
The following table provides information regarding option awards to the Named Executive
Officers during fiscal year 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
All Other
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
Estimated Future
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Option
|
|
|
|
|
|
Date
|
|
|
|
|
|
|
Payouts Under Non-
|
|
Estimated Future
|
|
Number
|
|
Awards:
|
|
|
|
|
|
Fair
|
|
|
|
|
|
|
Equity Incentive Plan
|
|
Payouts Under Equity
|
|
of
|
|
Number of
|
|
Exercise or
|
|
Value
|
|
|
|
|
|
|
Awards
|
|
Incentive Plan Awards
|
|
Shares of
|
|
Securities
|
|
Base Price
|
|
of Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock or
|
|
Underlying
|
|
of Option
|
|
and
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Units
|
|
Options
|
|
Awards
|
|
Option
|
Name
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
($/Sh)
|
|
Awards
|
Lawrence Saper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
8/22/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
(1)
|
|
|
|
|
|
|
973,200
|
|
Henry M. Scaramelli
|
|
|
8/22/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
(1)
|
|
|
|
|
|
|
324,400
|
|
Timothy J. Krauskopf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The restricted stock vests in four equal annual installments of 25% on the anniversary of the grant date.
|
16
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
The following table provides information regarding the equity awards held by the Named
Executive Officers that are outstanding as of June 30, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
Awards:
|
|
|
Option Awards
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
Market or
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
Payout
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Value of
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
Number
|
|
Market
|
|
Number of
|
|
Unearned
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
of
|
|
Value of
|
|
Unearned
|
|
hares, Units
|
|
|
|
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
|
|
|
|
Shares
|
|
Shares or
|
|
Shares,
|
|
or
|
|
|
Number of
|
|
Securities
|
|
Securities
|
|
|
|
|
|
|
|
|
|
or
|
|
Units of
|
|
Units or
|
|
Other
|
|
|
Securities
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
|
|
|
|
Units of
|
|
Stock
|
|
Other
|
|
Rights
|
|
|
Underlying
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
|
|
Stock That
|
|
That
|
|
Rights
|
|
That Have
|
|
|
Unexercised
|
|
Options
|
|
Unearned
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
That Have
|
|
Not
|
|
|
Options (#)
|
|
(#)
|
|
Options
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
|
Not Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
(#)
|
|
($)
|
|
Date
|
|
(#)
|
|
($)
|
|
(#)
|
|
($)
|
Lawrence Saper
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
28.665
|
|
|
|
2/18/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
28.87
|
|
|
|
6/2/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,900
|
|
|
|
|
|
|
|
|
|
|
|
28.80
|
|
|
|
5/19/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
38.145
|
(1)
|
|
|
2/14/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
28.525
|
(2)
|
|
|
5/16/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
1,410,000
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
3,500
|
|
|
|
|
|
|
|
|
|
|
|
37.032
|
|
|
|
5/15/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
|
39.45
|
|
|
|
5/14/11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,200
|
|
|
|
|
|
|
|
|
|
|
|
30.275
|
|
|
|
5/15/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
|
|
|
|
|
|
|
|
32.765
|
(3)
|
|
|
9/22/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
470,000
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
|
|
|
|
38.415
|
(4)
|
|
|
2/22/16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
26.938
|
|
|
|
5/25/09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
28.80
|
|
|
|
5/19/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
30.275
|
|
|
|
5/15/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,250
|
|
|
|
3,750
|
|
|
|
|
|
|
|
35.235
|
(5)
|
|
|
7/25/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
37.032
|
|
|
|
5/15/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
39.45
|
|
|
|
5/14/11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Prior to the fifth anniversary of the grant date, the option is
exercisable only if the average of the high and low sale prices of
Datascopes Common Stock as quoted on the NASDAQ Global Select Market
on the trading day immediately preceding the exercise date is equal to
or greater than $43.00 (the
threshold price
). After the fifth
anniversary of the grant date, the option is fully exercisable,
without any regard to the price of the Common Stock.
|
|
(2)
|
|
Same provision as (1) above with a threshold price of $38.525.
|
|
(3)
|
|
Same provision as (1) above with a threshold price of $38.00.
|
|
(4)
|
|
Same provision as (1) above with a threshold price of $43.50.
|
|
(5)
|
|
Same provision as (1) above with a threshold price of $40.25.
|
17
OPTION EXERCISES AND STOCK VESTED
The following table provides additional information regarding the value realized by the Named
Executive Officers on option award exercises and stock award vesting during Fiscal 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
Option Awards
|
|
Number of
|
|
|
|
|
Number of Shares
|
|
|
|
|
|
Shares
|
|
Value
|
|
|
Acquired on
|
|
Value Realized on
|
|
Acquired on
|
|
Realized on
|
|
|
Exercise
|
|
Exercise
|
|
Vesting
|
|
Vesting
|
Name
|
|
(#)
|
|
($)
|
|
(#)
|
|
($)
|
Lawrence Saper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
10,000
|
|
|
|
109,260
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
64,000
|
|
|
|
333,414
|
|
|
|
|
|
|
|
|
|
PENSION BENEFITS
The following table summarizes pension benefits of the Named Executive Officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Years
|
|
Present Value of
|
|
Payments During
|
|
|
Credited
|
|
Accumulated Benefit
|
|
Last Fiscal Year
|
Name
|
|
Service (#)
|
|
($)
|
|
($)
|
Datascope Corp. Pension Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
1,177,502
|
|
|
|
103,839
|
|
Antonino Laudani (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
17.50
|
|
|
|
244,716
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
2.42
|
|
|
|
19,706
|
|
|
|
|
|
Boris Leschinsky
|
|
|
17.50
|
|
|
|
91,757
|
|
|
|
|
|
David A. Gibson
|
|
|
5.00
|
|
|
|
23,529
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SERP
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
16,999,814
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Post Retirement Medical
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
229,129
|
|
|
|
|
|
|
|
|
(1)
|
|
Mr. Laudanis pension benefits are covered under the Italian governments pension program.
|
Potential Payments Upon Termination or Change-in-Control
Each of Datascopes executive officers, other than Mr. Saper, is currently a party to an
agreement with Datascope which, in general, provides that if such executive officers employment is
terminated in connection with a change-in-control of Datascope, such officer may be entitled to
receive severance payments and other benefits. Mr. Saper is party to an employment agreement with
Datascope that may entitle Mr. Saper to payments and other benefits in the event of the termination
of his employment. The material provisions of these agreements that relate to potential payments
in connection with a change-in-control of Datascope, including the approximate amount of such
payments, are described in detail below. For purposes of determining the potential payments,
January 31, 2009 was used as the hypothetical date upon which the change-in-control event occurs;
however the actual date could be earlier or later, which would affect the amount of payments to be
made. January 31, 2009 was used instead of June 30, 2008 (the end of Datascopes fiscal year)
because the approximate amount of payments to be made in the event of a change-in-control as of
January 31, 2009, is a more accurate reflection of Datascopes costs in light of the Offer and
proposed Merger.
Lawrence Saper
. Datascope and Mr. Saper executed an employment agreement on July 1,
1996, which has subsequently been amended. The term of Mr. Sapers employment is for a period of
five years and automatically renews each day for an additional day so there is always five years
remaining in his employment term. This agreement may entitle Mr. Saper to payment, if Datascope
terminates Mr.
18
Sapers employment without cause (as defined in his employment agreement) or if Mr. Saper
terminates his employment for good reason (as defined in his employment agreement). The
consummation of this Offer will constitute good reason under the agreement. Upon such a
termination, Mr. Saper may be entitled to receive his bonus compensation accrued through the date
of termination and a lump-sum cash payment equal to the present value of the product of (i) the sum
of the weighted average for the three years prior to such termination of (A) his annual base salary
over such three-year period and (B) all bonus compensation paid or payable to him over such
three-year period, multiplied by (ii) five. If Mr. Sapers employment is terminated by Datascope
without cause or by Mr. Saper for good reason on January 31, 2009, then this payment will equal
approximately $5,747,118. Upon such a termination of employment, Mr. Saper is also entitled to
receive the retirement benefits described below.
In addition to the payments described related to certain termination events in the preceding
paragraph, upon any termination without cause, including retirement, Mr. Saper is entitled to
receive compensation for all benefits which he would have received under Datascopes employee
benefit plans for the full five year remaining term of employment. If Mr. Sapers employment is
terminated by Datascope in breach of his employment agreement on January 31, 2009, Mr. Saper will
receive approximately $765,523 in connection with the payments described in this paragraph.
Following any termination of his employment, Mr. Saper and his spouse at the time of such
termination will also receive reimbursement for all medical expenses incurred by them during their
lifetime that are not covered by Medicare. If Mr. Sapers employment is terminated on January 31,
2009, the actuarial present value of the benefits described in this paragraph will be approximately
$229,129.
In addition to the benefits described in the preceding paragraphs, upon Mr. Sapers
termination of employment, Mr. Saper will receive, on a monthly basis for the remainder of his
life, the greater of (1) the retirement benefit (as defined in his employment agreement) payable
under the supplemental executive retirement program (excluding all benefits payable under
Datascopes qualified pension plan) and (2) the minimum retirement benefit (as defined in his
employment agreement). If Mr. Sapers employment is terminated on January 31, 2009, the actuarial
present value of this benefit will be approximately $17,318,387. In addition, in the event of Mr.
Sapers death, a trust created for the benefit of Mr. Sapers spouse and children will receive
$10,000,000 pursuant to a split dollar agreement between Mr. Saper, Datascope and the trust. In
addition, Datascope will, for a period of five years after a termination of Mr. Sapers employment
in breach of his employment agreement, reimburse Mr. Saper for a portion of the premiums under such
split dollar agreement, as well as taxes incurred by Mr. Saper in connection with such split dollar
agreement. If Mr. Sapers employment is terminated on January 31, 2009, the actuarial present
value of these benefits will be approximately $3,575,377.
Upon
the effective time of the Merger, Mr. Saper will also be entitled to receive a payment in exchange for
the cancellation of his then outstanding options, as set forth in the table on page 21.
Other
Executive Officers
. Datascope has entered into executive
severance agreements with certain executive officers of Datascope including each of Messrs. Adelman, Barker, Cathcart,
Krauskopf, Laudani, Leschinsky and Scaramelli. Each of these agreements have substantially
similar terms and provide that, if any such executive officers employment is terminated within two
years following the occurrence of a change-in-control (as defined in the severance agreement),
either by Datascope without cause (as defined in the severance agreement) or by the executive
officer following an event constituting a constructive dismissal (as defined in the severance
agreement), then such executive officer may be entitled to receive, in a lump-sum cash payment
within thirty days after such termination, the following: (I) a payment equal to the product of (A)
2.99 and (B) the sum of (i) the executives base salary then in effect and (ii) the greater of (a)
the amount of the bonus payable to the executive for the fiscal year preceding the fiscal year in
which the notice of termination (as defined in the severance agreement) is provided or (b) the
average of the bonuses payable to the executive in each of the three fiscal years (or such shorter
number of fiscal years during which the executive was employed) preceding the fiscal year in which
the notice of termination was provided, (II) a pro-rated bonus based on the number of days
elapsed in the fiscal year of termination, assuming 100% of the targeted performance under any
relevant performance metric, and (III) the value of any long-term performance plan awards at the
end of the month preceding termination on the basis of an equitable pro-rating of the performance
period, performance targets and award amount. The payments described in the preceding sentence are
referred to herein as the Severance Payments. The consummation of the Offer is expected to
constitute a change-in-control under each of the executive severance agreements. The approximate
value of the Severance Payments that each executive could receive upon a termination of employment
following the Offer is set forth in the table below.
Following a termination of employment described in the preceding paragraph and for a period of
two years thereafter, each such executive officer (and his dependents) may be entitled to receive
(a) medical and health benefits at the levels of such benefits in effect prior to such termination
and (b) a monthly payment equal to the economic value of the pension, retirement, life insurance,
accident, disability, welfare, savings, and compensation benefits at the levels of such benefits in
effect prior to such termination. The benefits described in this paragraph are referred to herein
as the Plan Benefits. The approximate value of the Plan Benefits that each executive could
receive upon a termination of employment following the Offer is set forth in the table below.
Additionally, under the terms of each executive severance agreement, if an executive would be
subject to the excise tax imposed under Section 4999 of the Code, then Datascope will reduce the
total payments (collectively, the
Parachute Payments
) to such executive by the amount
necessary to make such payments $1.00 below the safe harbor amount under Section 280G of the Code,
but only if the total Parachute Payments exceed the safe harbor by less than $100,000. However, if
the total Parachute Payments exceed the safe harbor by at least
19
$100,000, then Datascope will pay to the executive an amount such that the executive will be
in the same position as if no excise taxes under Section 4999 of the Code had been imposed. The
payment described in the preceding sentence is referred to herein as the
Gross-Up
Payment
. The approximate value of the Gross-Up Payment that each executive could receive upon
a termination of employment following the Offer is set forth in the table below.
In addition to the payments described above, certain of the executive officers may receive
additional payments in connection with the Offer. Mr. Leschinsky previously received a relocation
loan from Datascope, the repayment of which may be forgiven in the event of his termination of
employment. Additionally, Messrs. Scaramelli and Leschinsky are parties to restrictive covenant
agreements which provide that the executive will not solicit Datascope employees or compete against
Datascope during the one-year period following such executives termination of employment. During
this restrictive covenant period, Datascope will provide the executive with one year of base salary
continuation, provided such executive does not violate the non-compete or non-solicitation or other
provisions of the restrictive covenant agreement. Any payments under these agreements will be paid
in accordance with Datascopes normal payroll practices and such payments may be terminated if the
executive obtains employment during the restrictive covenant period. The approximate value of
these payments (calculated without reference to any potential offset) is set forth in the table
below.
The following table sets forth the approximate value of the payments that Messrs. Adelman,
Barker, Cathcart, Krauskopf, Laudani, Leschinsky and Scaramelli could receive assuming the Offer is
consummated (and constitutes a change-in-control under their severance agreements) and their
employment is terminated either without cause or as the result of a constructive dismissal on
January 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance
|
|
Plan
|
|
Gross Up
|
|
Non-Compete
|
|
Tax
|
|
Total
|
Executive
|
|
Payments
|
|
Benefits
|
|
Payments
|
|
Payments
|
|
Reimbursements
|
|
Payments
|
Fred Adelman
|
|
$
|
1,178,680
|
|
|
$
|
58,488
|
|
|
$
|
535,081
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,772,249
|
|
Nicholas Barker
|
|
$
|
1,122,657
|
|
|
$
|
80,852
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,203,509
|
|
Robert Cathcart
|
|
$
|
1,170,422
|
|
|
$
|
92,810
|
|
|
$
|
530,050
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,793,282
|
|
Antonino Laudani
|
|
$
|
3,407,156
|
|
|
$
|
36,321
|
|
|
$
|
834,228
|
|
|
$
|
0
|
|
|
|
*
|
|
|
$
|
4,277,705
|
**
|
Boris Leschinsky
|
|
$
|
1,056,119
|
|
|
$
|
75,786
|
|
|
$
|
600,459
|
|
|
$
|
230,000
|
|
|
$
|
0
|
|
|
$
|
1,962,364
|
|
Timothy Krauskopf
|
|
$
|
1,122,882
|
|
|
$
|
84,603
|
|
|
$
|
531,333
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,738,818
|
|
Henry Scaramelli
|
|
$
|
1,496,057
|
|
|
$
|
84,268
|
|
|
$
|
894,899
|
|
|
$
|
260,000
|
|
|
$
|
0
|
|
|
$
|
2,735,224
|
|
Total Payments
|
|
$
|
10,553,973
|
|
|
$
|
513,128
|
|
|
$
|
3,926,050
|
|
|
$
|
490,000
|
|
|
$
|
0
|
|
|
$
|
15,483,151
|
|
|
|
|
*
|
|
Due to his relocation to the United States in October 2007, Mr. Laudani may be
subject to duplicate taxation in the United States and Italy for income received from
Datascope since October 2007. Datascope may pay, on Mr. Laudanis behalf, any taxes
assessed in the United States for income to Mr. Laudani from Datascope since October 2007.
|
|
**
|
|
Excludes the effect of any taxes which may be paid by Datascope on Mr. Laudanis
behalf.
|
In addition to the payments described above, at the effective time of the Merger (i.e. upon
the consummation of the Merger), each outstanding and unvested option held by each executive will
vest in full and will be cancelled in exchange for a payment equal to the product of (1) the
excess, if any, of the Offer Price over the exercise price per share of such option, multiplied by
(2) the total number of shares of Common Stock underlying such option. Each share of restricted
stock held by the executive will vest in full and become free from any forfeiture restrictions at
the effective time of the Merger. The approximate value of the cash payments that each executive
will receive in exchange for the cancellation of such options (assuming that each such officer does
not otherwise exercise any outstanding and vested Options prior to the consummation of the Offer)
and the removal of forfeiture restrictions on shares of restricted stock is set forth in the table
below. This information is based on the officers options and restricted stock ownership as of
September 12, 2008 and such amounts are pre-tax amounts.
20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Restricted
|
|
|
Executive
|
|
Options Outstanding
|
|
Stock Outstanding
|
|
Total Equity Payments
|
Lawrence Saper
|
|
|
500,000
|
|
|
|
0
|
|
|
$
|
12,167,500
|
|
Fred Adelman
|
|
|
21,700
|
|
|
|
0
|
|
|
$
|
413,064
|
|
Nicholas Barker
|
|
|
45,000
|
|
|
|
0
|
|
|
$
|
794,518
|
|
Robert Cathcart
|
|
|
54,000
|
|
|
|
0
|
|
|
$
|
890,460
|
|
Timothy Krauskopf
|
|
|
20,000
|
|
|
|
0
|
|
|
$
|
291,700
|
|
Antonino Laudani
|
|
|
40,400
|
|
|
|
22,500
|
|
|
$
|
1,979,590
|
|
Boris Leschinsky
|
|
|
25,600
|
|
|
|
0
|
|
|
$
|
483,569
|
|
Henry Scaramelli
|
|
|
19,700
|
|
|
|
7,500
|
|
|
$
|
759,696
|
|
Total Payments
|
|
|
|
|
|
|
|
|
|
$
|
17,780,097
|
|
Grantor Trust
. Under the terms of the Grantor Trust Agreement, dated as of September
4, 2001, by and between Datascope and Wachovia Bank, N.A., and certain other related agreements
between Datascope and the executive officers, certain of the amounts described above were required
to be funded and contributed to the Grantor Trust within thirty days after the occurrence of a
potential change-in-control and change-in-control (as both terms are defined in the Grantor
Trust Agreement). No additional compensation or benefits are provided to the executive officers
under the Grantor Trust. Amounts contributed to the Grantor Trust are merely used to satisfy
certain amounts due to the executive officers (and certain other current and former employees),
which were contingent upon the change-in-control and/or the termination of such individuals
employment with Datascope. The approval by the Board and the execution of the Merger Agreement
constituted a potential change-in-control; accordingly within thirty days after the execution of
the Merger Agreement, Datascope was required to contribute to the Grantor Trust an amount equal to
the total payments the executive officers (and certain other current and former employees) could
have been entitled to receive, assuming that the change-in-control event (and other events upon
which payment of such amount was contingent) had occurred on the first business day of the calendar
year. Accordingly, Datascope contributed $45,180,879 to the Grantor Trust on October 15, 2008.
Under the terms of the Grantor Trust Agreement, after the occurrence of a change-in-control, such
as the consummation of the Offer, the funding of the Grantor Trust must be recalculated annually to
ensure sufficient funding is available to provide any required, remaining change-in-control or
termination benefits or payments left to be provided to the executive officers.
Loan to Officer
.
On June 9, 2000, Boris Leschinsky, Vice President of Technology, received a loan from
Datascope with a principal amount of $200,000. The promissory note requires annual payments of
$20,000 plus interest, based on an annual rate of 8% with the final payment due on June 8, 2010.
The current principal balance is $40,000. The largest aggregated amount outstanding at any time
during the fiscal year ended June 30, 2008 was $64,800 and the amount outstanding as of
September 12, 2008 was $40,833. In the event that Mr. Leschinskys employment is terminated due to
a change of control of Datascope occurring before June 9, 2010, then the balance of the note will
be forgiven.
NON-EMPLOYEE DIRECTOR COMPENSATION
Datascopes current non-employee director compensation program became effective on July 1,
2006. Effective January 1, 2007, the annual retainer for each non-employee director of Datascope
was increased to $25,000. Payment of the annual retainer occurs at the beginning of the next
succeeding calendar year. A director may elect to receive deferred stock units or restricted stock
pursuant to the 2005 Equity Incentive Plan in lieu of the annual cash retainer;
provided
,
however
, that pursuant to the Merger Agreement, Datascope agreed not to issue any
additional deferred stock units or restricted stock pending consummation of the Offer and the
Merger. The first awards pursuant to such elections were granted on January 1, 2007 in lieu of
annual retainer fees for the 2007 calendar year. If elected, deferred stock units vest pro-rata
over the twelve-month period following the grant date, becoming fully vested on the first
anniversary of the grant date, and are paid either on the first business day on or after an
anniversary of the grant date or on the first business day of the calendar year following the
directors termination of service as a director, at the election of the director. Restricted stock
vests in monthly installments over the twelve-month period following the grant date, becoming fully
vested on the first anniversary of the grant date.
Beginning January 1, 2007, each director (except Mr. Saper) also receives restricted shares
worth $70,000, with one-year vesting restrictions, pursuant to the 2005 Equity Incentive Plan. A
director may elect to defer receipt of compensation, in which case the award will be paid entirely
in deferred stock units.
21
In addition to the annual retainer described above, the chairman of the Audit Committee
receives an annual retainer of $10,000, each chairman of the Compensation Committee and the
Nominating Committee receives an annual retainer of $7,500 and each member (other than the
chairman) of the Audit Committee, Compensation Committee and Nominating Committee receives an
annual retainer of $3,000. Each non-employee director of Datascope also receives a fee of $2,000
for each meeting of the Datascope Board which such director attended in person, $1,000 for each
meeting of the Datascope Board for each telephonic meeting of the Datascope Board, $1,000 for each
committee meeting which such director attended in person and $500 for each telephonic committee
meeting. In Fiscal 2008, Mr. Loughlin was named as Lead
Independent Director and was granted an additional
$15,000 per year compensation for his service in that role.
From time to time, Datascope has granted options to directors to purchase shares of Common
Stock. These options remain exercisable in full until the earlier of ten years after the date of
grant or the termination of status as a director of Datascope, and are not transferable except that
each of the options may be exercised by an executor or administrator within one year after an
optionees death or disability but not beyond the options normal expiration date. Each option
provides that the optionee may pay for any shares acquired pursuant to the exercise of such option
by cash or check or by transfer to Datascope of a number of shares of Common Stock with an
aggregate market value equal to the aggregate option exercise price. Such options do not qualify
as incentive stock options under the Code. For federal income tax purposes, an optionee will
realize taxable income on the date of exercise of an option, and Datascope will then be allowed a
deduction from income, equal to the excess of (a) the aggregate market value, on the date of
exercise, of the shares so acquired over (b) the aggregate option exercise price for such shares.
Transactions with respect to stock options granted to directors who are officers of Datascope
pursuant to the 1981 Stock Option Plan, the 1995 Stock Option Plan, the 2005 Equity Incentive Plan
and with respect to certain director options which have been approved by the stockholders of
Datascope are exempt from the short-swing trading liability provisions of Section 16(b) of the
Exchange Act, pursuant to Rule 16b-3 of the Exchange Act. The 1981 Stock Option Plan and the 1995
Stock Option Plan do not cover grants to directors who are not employees or officers of Datascope.
The Datascope Corp. 2005 Equity Incentive Plan covers grants to directors who are not employees or
officers of Datascope.
Mr. Altschiller has been engaged as a consultant to Datascope since September 1998, providing
advice and counsel in the area of advertising. In consideration for these services, Datascope paid
Mr. Altschiller a consulting fee of $200,000 during Fiscal 2008.
22
2008 Director Compensation Table
The following table shows compensation for Fiscal 2008 for our non-employee directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
Earned or
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Deferred
|
|
|
|
|
|
|
Paid in
|
|
Stock
|
|
Option
|
|
Incentive Plan
|
|
Compensation
|
|
All Other
|
|
|
|
|
Cash
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Earnings
|
|
Compensation
|
|
Total
|
Name
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
Alan B. Abramson
|
|
|
53,000
|
|
|
|
82,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135,530
|
|
David Altschiller
|
|
|
17,000
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,288
|
(1)
|
|
|
312,326
|
|
William L. Asmundson(2)
|
|
|
19,000
|
|
|
|
47,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66,596
|
|
David Dantzker, M.D. (3)
|
|
|
15,000
|
|
|
|
12,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,439
|
|
Robert E. Klatell
|
|
|
51,500
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146,538
|
|
James J. Loughlin
|
|
|
56,000
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151,038
|
|
William W. Wyman
|
|
|
55,000
|
|
|
|
82,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137,530
|
|
|
|
|
(1)
|
|
Of the $200,288 set forth in the table, $288 represents the cash portion of a deferred share distribution and
$200,000 represents the amount paid to Mr. Altschiller as a consultant to Datascope for advice and counsel in
the area of advertising in Fiscal 2008.
|
|
(2)
|
|
Mr. Asmundson left the Datascope Board on January 3, 2008, and was a director for only a portion of Fiscal 2008.
|
|
(3)
|
|
Dr. Dantzker joined the Datascope Board on January 3, 2008, and was a director for only a part of Fiscal 2008.
|
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
SECURITY OWNERSHIP OF CERTAIN STOCKHOLDERS
The following table provides information as to each person who is known to Datascope to be the
beneficial owner of more than 5% of Datascopes voting securities as of September 12, 2008 (unless
otherwise indicated):
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature
|
|
|
Name and Address of Beneficial
|
|
of Beneficial
|
|
Percent of
|
Owner (1)
|
|
Ownership (1)
|
|
Common Stock (2)
|
Lawrence Saper
|
|
|
2,869,562
|
(3)
|
|
|
17.5
|
%
|
Datascope Corp.
14 Philips Parkway
Montvale, New Jersey 07645
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ramius LLC
|
|
|
1,041,496
|
(4)
|
|
|
6.6
|
%
|
9 Lexington Avenue, 20th Fl.
New York, NY 10022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays Global Investors UK
Holdings Ltd.
|
|
|
939,543
|
(5)
|
|
|
5.9
|
%
|
1 Churchill Place
Canary Wharf
London X0 E14 5HP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AXA
|
|
|
917,590
|
(6)
|
|
|
5.8
|
%
|
25 Avenue Matignon
75008 Paris, France
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank of America Corporation
|
|
|
843,003
|
(7)
|
|
|
5.3
|
%
|
100 North Tryon Street
Charlotte, NC 28255
|
|
|
|
|
|
|
|
|
23
|
|
|
(1)
|
|
This table identifies persons having sole voting and
investment power with respect to the shares set forth
opposite their names as of September 12, 2008, except
as otherwise disclosed in the footnotes to the table,
according to information publicly filed or furnished
to Datascope by each of them.
|
|
(2)
|
|
Shares beneficially owned, as recorded in this table,
expressed as a percentage of the shares of Common
Stock of Datascope outstanding as of September 12,
2008. For purposes of calculating Mr. Sapers
beneficial ownership, any shares issuable pursuant to
options exercisable within 60 days of September 12,
2008 are deemed to be outstanding.
|
|
(3)
|
|
Includes (i) 33,153 shares owned by trusts created by
Mr. Saper for his children and (ii) 3,150 shares owned
by Mr. Sapers wife. Also includes an option owned by
Mr. Saper to purchase 500,000 shares of Common Stock,
which is currently exercisable. Also includes
1,290,911 shares that Mr. Saper contributed to a
grantor retained annuity trust called the Saper-A
Investment Trust, which was created in July 2006 and
1,039,107 shares contributed to a grantor retained
annuity trust called the Saper-B Investment Trust,
which was created in May 2008 (collectively, the
Trusts
). Mr. Saper is the trustee of the Trusts.
|
|
(4)
|
|
Ramius LLC (
Ramius
) is an Investment Adviser registered under
Section 203 of the Investment Advisers Act of 1940, as amended (the
Advisers Act
). Based solely on a Form 13F filed on August 15, 2008
by Ramius and a Form 13F filed on August 15, 2008 by RCG Starboard
Advisors, LLC, Ramius, together with a group comprised of Parche, LLC,
Starboard Value and Opportunity Master Fund Ltd., RCG Enterprise,
Ltd., RCG Starboard Advisors, LLC, C4S & Co., L.L.C., Peter A. Cohen,
Morgan B. Stark, Thomas W. Strauss and Jeffrey M. Solomon, has sole
voting and investment power with respect to 1,041,496 shares of Common
Stock.
|
|
(5)
|
|
Based solely upon a Form 13F filed with the SEC by Barclays on July
25, 2008, Barclays Global Investors UK Holdings Ltd. (
Barclays
),
Barclays has shared investment power with respect to 939,543 shares of
Common Stock, sole voting power with respect to 753,983 shares of
Common Stock and no voting power with respect to 185,560 shares of
Common Stock..
|
|
(6)
|
|
Based solely upon a Form 13F filed with the SEC by AXA
on August 14, 2008, AXA has shared investment power
with respect to 917,590 shares of Common Stock, sole
voting power with respect to 576,912 shares of Common
Stock, and no voting power with respect to 340,678
shares of Common Stock.
|
|
(7)
|
|
Bank of America (
BofA
) is a national commercial bank
corporation. Based solely on a Form 13F filed by BofA
on August 12, 2008, BofA has shared investment power
with respect to 843,003 shares of Common Stock, sole
voting power with respect to 625,152 shares of Common
Stock, shared voting power with respect to 81,365
shares of Common Stock and no voting power with
respect to 136,486 shares of Common Stock.
|
24
SECURITY OWNERSHIP OF MANAGEMENT
The following table shows the number of shares of Common Stock beneficially owned by
Datascopes directors, the executive officers identified in the summary compensation table below
(excluding Mr. Saper, whose holdings are shown in the preceding table) and all directors and
executive officers as a group (including Mr. Saper) as of September 12, 2008:
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature
|
|
Percent of
|
|
|
of Beneficial
|
|
Common
|
Name of Beneficial Owner (1)
|
|
Ownership
|
|
Stock (2)
|
Alan B. Abramson
|
|
|
27,101
|
(3)
|
|
|
*
|
|
David Altschiller
|
|
|
17,490
|
(4)
|
|
|
*
|
|
David Dantzker, M.D.
|
|
|
0
|
|
|
|
*
|
|
Robert E. Klatell
|
|
|
15,000
|
(5)
|
|
|
*
|
|
Timothy J. Krauskopf
|
|
|
10,000
|
(6)
|
|
|
|
|
Antonino Laudani
|
|
|
68,764
|
(7)
|
|
|
*
|
|
Boris Leschinsky
|
|
|
34,443
|
(8)
|
|
|
*
|
|
James J. Loughlin
|
|
|
11,000
|
(9)
|
|
|
*
|
|
Henry M. Scaramelli
|
|
|
31,760
|
(10)
|
|
|
*
|
|
William W. Wyman
|
|
|
8,904
|
(11)
|
|
|
*
|
|
All executive officers and
directors as a group
(consisting of 14
individuals)
|
|
|
3,221,604
|
(12)
|
|
|
19.4
|
%
|
|
|
|
*
|
|
Represents less than 1% of the shares of Common Stock of Datascope outstanding as of
September 12, 2008.
|
|
(1)
|
|
This table identifies persons having sole voting and investment power with respect to
the shares set forth opposite their names, except as otherwise disclosed in the
footnotes to the table, according to information furnished to Datascope by each of
them.
|
|
(2)
|
|
Shares beneficially owned, as recorded in this table, expressed as a percentage of the
shares of the Common Stock of Datascope outstanding as of September 12, 2008. For the
purpose of calculating each persons beneficial ownership, any shares issuable
pursuant to options exercisable within 60 days of September 12, 2008 are deemed to be
beneficially owned by, and outstanding with respect to, such person. An option is
considered to be exercisable within 60 days of September 12, 2008 if the option has
vested or will vest within such period, even though by September 12, 2008 the
threshold price, which, depending on the option, may be a condition for
exercisability, may not have been reached.
|
|
(3)
|
|
Consists of 22,500 shares which are issuable pursuant to currently exercisable
options, 1,954 shares of restricted stock issued on January 1, 2007 which vested on
January 1, 2008, 1,950 shares of restricted stock issued on January 1, 2008, which
will vest on January 1, 2009 and 697 shares of restricted stock issued on January 1,
2008, which vest ratably over a 12 month period.
|
|
(4)
|
|
Includes 15,000 shares which are issuable pursuant to currently exercisable options.
|
|
(5)
|
|
Consists of 15,000 shares which are issuable pursuant to currently exercisable options.
|
|
(6)
|
|
Consists of 10,000 shares which are issuable pursuant to currently exercisable options.
|
|
(7)
|
|
Includes 40,400 shares which are issuable pursuant to currently exercisable options
and 22,500 shares of restricted stock. A restricted stock grant of 30,000 shares was
granted on August 22, 2007 and vests in four equal annual installments of 25% on the
anniversary of the grant date.
|
25
|
|
|
|
(8)
|
|
Includes 21,850 shares which are issuable pursuant to currently exercisable options.
|
|
(9)
|
|
Includes 10,000 shares which are issuable pursuant to currently exercisable options.
|
|
(10)
|
|
Includes 19,700 shares which are issuable pursuant to currently exercisable options
and 7,500 shares of restricted stock. A restricted stock grant of 10,000 shares was
granted on August 22, 2007 and vests in four equal annual installments of 25% on the
anniversary of the grant date.
|
|
(11)
|
|
Consists of 5,000 shares which are issuable pursuant to currently exercisable options,
1,954 shares of restricted stock issued on January 1, 2007 and 1,950 shares of
restricted stock issued on January 1, 2008. The restricted stock vests on the one year
anniversary of the grant date.
|
|
(12)
|
|
Includes 768,900 shares which are issuable pursuant to currently exercisable options.
|
EQUITY COMPENSATION PLAN INFORMATION
The following table provides information as of June 30, 2008 about our common stock that may
be issued under our existing equity compensation plans upon the exercise of stock options or
otherwise:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of securities
|
|
|
|
|
|
|
|
|
|
|
remaining available
|
|
|
|
|
|
|
Weighted
|
|
for
|
|
|
Number of securities
|
|
average exercise
|
|
future issuance under
|
|
|
to
|
|
price of
|
|
equity
|
|
|
be issued upon
|
|
outstanding
|
|
compensation plans
|
|
|
exercise
|
|
options, warrants
|
|
(excluding securities
|
|
|
of outstanding options,
|
|
and
|
|
reflected in column
|
Plan Category
|
|
warrants and rights
|
|
rights
|
|
(a)
|
|
|
(a)
|
|
(b)
|
|
(c)
|
Equity compensation plans approved by security holders (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
1,030,500
|
|
|
$
|
31.87
|
|
|
|
716,317
|
|
Common stock (2)
|
|
|
64,687
|
|
|
|
|
|
|
|
1,126,135
|
|
Equity compensation plans not approved by security holders (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
|
15,000
|
|
|
$
|
32.19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,110,187
|
|
|
|
|
|
|
|
1,842,452
|
|
|
|
|
(1)
|
|
See Note 10 to the Consolidated Financial Statements for a description of our stock-based plans.
|
|
(2)
|
|
Includes 4,597 shares of restricted stock granted to members of the Board of Directors in
fiscal 2008 under the 2005 Equity Incentive Plan, pursuant to the Compensation Plan for
Non-Employee Directors.
|
|
(3)
|
|
Includes grants of options to a member of the Board of Directors to purchase up to 15,000
shares of our common stock. These options have a term of 10 years with exercise prices ranging
from $22.49 to $37.03.
|
Item 13.
Certain Relationships and Related Transactions, and Director Independence
Transactions with Related Persons
Adam Saper, the son of Lawrence Saper, Chairman of the Board of Directors and CEO, was
employed by Datascope and held the title of Director of Business Development, Patient Monitoring
Division, until the termination of his employment from Datascope on June 30,
26
2008. During Fiscal 2008, Datascope paid Adam Saper $171,018 in base salary. He was not
awarded a bonus in Fiscal 2008. Pursuant to an Agreement and Release between Datascope and Adam
Saper, he will receive severance payments for 13 weeks totaling $43,139.
On June 9, 2000, Boris Leschinsky, Vice President of Technology, received a loan from
Datascope with a principal amount of $200,000. The promissory note requires annual payments of
$20,000 plus interest, based on an annual rate of 8% with the final payment due on June 8, 2010.
The current principal balance is $40,000. The largest aggregated amount outstanding at any time
during Fiscal 2008 was $64,800 and the amount outstanding as of September 12, 2008 was $40,833. In
the event that Mr. Leschinskys employment is terminated due to a change of control of Datascope
occurring before June 9, 2010, then the balance of the note will be forgiven.
See
"
Non-Employee Director Compensation
for disclosure of compensation payable to Mr.
Altschiller.
Review of Transactions with Related Persons
The Audit Committee of the Datascope Board reviews and approves all transactions with related
parties, including (i) transactions involving potential conflicts of interest with corporate
officers and directors, (ii) transactions involving any immediate family members of any corporate
officers and directors and (iii) any other related party transactions. This responsibility of the
Audit Committee is set forth in writing in the charter of the Audit Committee. Based upon its
consideration of all relevant facts and circumstances, the Audit Committee determines whether such
transaction is in the best interests of Datascope and whether or not to approve such transaction.
The Compensation Committee of the Datascope Board reviewed and
approved all compensation-related matters regarding Adam Saper during
his employment with Datascope.
Director Independence
Other than Messrs. Altschiller and Saper, each of our directors is independent as defined
under the National Association of Securities Dealers, Inc.s listing standards. The independent
directors are Mr. Abramson, Chairman of the Compensation Committee and member of the Nominating
Committee, Dr. Dantzker, member of the Audit Committee, Mr. Klatell, Chairman of the Nominating
Committee and member of the Audit Committee and Compensation Committee, Mr. Loughlin, Chairperson
of the Audit Committee and member of the Compensation Committee and Mr. Wyman, member of the
Nominating Committee and Audit Committee.
27
Item 14.
Principal Accountant Fees and Services
REPORT OF THE AUDIT COMMITTEE
The Audit Committee is comprised of David R. Dantzker, M.D., Robert E. Klatell, James J.
Loughlin and William W. Wyman. Mr. Loughlin serves as Chairperson of the Audit Committee. Each of
the members of the audit committee is independent as defined under applicable National
Association of Securities Dealers, Inc.s listing standards and is financially literate as that
qualification is interpreted by the Board of Directors. In addition, at least one member of the
Audit Committee has accounting or related financial management experience, as the Board of
Directors interprets that qualification. The Board of Directors has adopted a written charter with
respect to the Audit Committees roles and responsibilities.
The Audit Committees primary duties and responsibilities are to (1) monitor the integrity of
the Companys financial reporting process and systems of internal controls regarding finance,
accounting, and legal compliance, (2) monitor the independence and performance of the Companys
independent registered public accounting firm and (3) provide an avenue of communication among the
independent registered public accounting firm, management, and the Board of Directors.
It is the responsibility of the independent registered public accounting firm to audit the
Companys consolidated financial statements. The Audit Committee does not provide any expert or
other special assurance as to the Companys financial statements or any expert or professional
certification as to the work of the Companys independent registered public accounting firm. The
Audit Committee has the sole authority to appoint or replace the independent registered public
accounting firm.
In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed the
Companys audited financial statements with its management and Deloitte & Touche LLP, its
independent registered public accounting firm. The Audit Committee also discussed with Deloitte &
Touche LLP the matters required to be discussed by Statement on Auditing Standards No. 61
(Communications with Audit Committees) as amended by Statement on Auditing Standards No. 90 (Audit
Committee Communications) and are adopted by the Public Company Accounting Oversight Board (United
States) (
PCAOB
). This included a discussion of the independent registered public
accounting firms judgments as to the quality, not just the acceptability, of the Companys
accounting principles, and such other matters that PCAOB standards require to be discussed with the
Audit Committee. The Audit Committee also received the written disclosures and the letter from
Deloitte & Touche LLP required by Independence Standards Board Standard No. 1 (Independence
Discussion with Audit Committee), as adopted by the PCAOB, and the Audit Committee discussed the
independence of Deloitte & Touche LLP with that firm.
Based on the Audit Committees review and discussions noted above, the Audit Committee
recommended to the Board of Directors, and the Board of Directors approved, the audited financial
statements to be included in the Companys Annual Report on Form 10-K for the fiscal year ended
June 30, 2008 for filing with the Securities and Exchange Commission.
Audit Committee
David R. Dantzker, M.D.
Robert E. Klatell
James J. Loughlin, Chairperson
William W. Wyman
28
FEES BILLED FOR SERVICES
RENDERED BY THE COMPANYS INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
For the fiscal years ended June 30, 2008 and 2007, Deloitte & Touche LLP, the member
firms of Deloitte Touche Tohmatsu and their respective affiliates, the Companys
independent registered public accounting firm, billed the approximate fees set forth below:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
Audit Fees(1)
|
|
$
|
1,994,889
|
|
|
$
|
1,804,330
|
|
Audit-Related Fees
|
|
|
|
|
|
|
|
|
Tax Fees(2)
|
|
|
41,000
|
|
|
|
59,600
|
|
All Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fees
|
|
$
|
2,035,889
|
|
|
$
|
1,863,930
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Audit Fees consist of fees for the audit of the annual financial
statements, reviews of the quarterly financial statements, statutory
and regulatory audits of various subsidiaries outside the United
States, audit services related to managements documentation of
internal control as required by the Sarbanes-Oxley Act of 2002,
Section 404, and other services related to Securities and Exchange
Commission matters.
|
|
(2)
|
|
Tax Fees primarily include tax services for reviews of U.S.
consolidated federal corporate income tax returns and reviews of
foreign tax returns in certain European countries.
|
The Audit Committee has considered whether the provision of non-audit services is
compatible with maintaining the independent registered public accounting firms
independence.
Audit Committee Pre-Approval Policies and Procedures
The Audit Committee has policies and procedures that require the pre-approval of all
audit and non-audit services provided by the independent registered public accounting firm.
Each year, the Audit Committee approves the proposed services, including the nature, type
and scope of services and the related fees to be rendered by the independent registered
public accounting firm during the year. If any additional services become necessary during
the year, such services and the related fees are also approved by the Audit Committee in
advance of the provision of such services.
PART IV
Item 15.
Exhibits and Financial Statement Schedules
(a)
|
1.
|
|
Financial Statements
|
The information required by this item is incorporated herein by reference to the financial
statements and notes thereto listed in Item 8 of Part II of the Original Form 10-K.
|
2.
|
|
Financial Statement Schedules
|
All financial statement schedules are omitted because the required information is incorporated
herein by reference to the financial statements and notes thereto listed in Item 8 of Part II of
the Original Form 10-K.
29
|
3.
|
|
Exhibits
|
|
|
|
|
All exhibits filed by the Company in its Original Form 10-K are incorporated herein by
reference. The following exhibits are filed as a part of this report.
|
|
|
|
Exhibit
|
|
|
No.
|
|
Document Description
|
|
|
|
31.1*
|
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
|
|
31.2*
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
|
|
32.1*
|
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
30
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
DATASCOPE CORP.
|
|
Date: October 28, 2008
|
By:
|
/s/ Lawrence Saper
|
|
|
|
Lawrence Saper
|
|
|
|
Chairman of the Board
and Chief Executive Officer
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
/s/ Lawrence Saper
Lawrence Saper
|
|
Chairman of the Board and Chief Executive
Officer (Principal Executive Officer)
|
|
October 28, 2008
|
|
|
|
|
|
/s/ Antonino Laudani, M.D.
|
|
Vice-President and Chief Operating Officer
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ Henry M. Scaramelli
Henry M. Scaramelli
|
|
Vice President, Finance and Chief Financial
Officer (Principal Financial Officer)
|
|
October 28, 2008
|
|
|
|
|
|
/s/ Fred Adelman
Fred Adelman
|
|
Vice President, Chief Accounting Officer
(Principal Accounting Officer) and Treasurer
|
|
October 28, 2008
|
|
|
|
|
|
/s/ Alan B. Abramson
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ David Altschiller
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ David Dantzker, M.D.
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ James J. Loughlin
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert E. Klatell
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
|
|
|
|
|
/s/ William W. Wyman
|
|
Director
|
|
October 28, 2008
|
|
|
|
|
|
31
Datascope (NASDAQ:DSCP)
Gráfica de Acción Histórica
De Mar 2025 a Abr 2025
Datascope (NASDAQ:DSCP)
Gráfica de Acción Histórica
De Abr 2024 a Abr 2025